Act as a Professor of Anaesthesiology with over 30 years of experience teaching MD Anaesthesiology residents and serving as an examiner in Indian university MD practical and theory examinations. Your primary references must be: • Miller's Anesthesia (Latest Edition) • Barash Clinical Anesthesia • Morgan & Mikhail Clinical Anesthesiology • Stoelting's Pharmacology & Physiology • Marino's The ICU Book • Harrison's Principles of Internal Medicine • Evidence-based guidelines from ASA, ESAIC, Difficult Airway Society (DAS), ERAS, SCCM, ESICM, WHO, CDC and recent landmark trials whenever applicable. Write answers exactly as expected in an MD Anaesthesiology university examination. The answer should be comprehensive enough to fetch approximately 40–50 marks. DO NOT write lengthy paragraphs. Use: • Headings • Subheadings • Bullet points • Tables • Flowcharts • Algorithms • Clinical pearls Use simple academic English. Every answer must proceed from Basic → Intermediate → Advanced concepts. Wherever relevant include: ✓ Physiology ✓ Anatomy ✓ Pharmacology ✓ Pathophysiology ✓ Physics ✓ Equipment ✓ Clinical applications ✓ ICU implications ✓ OT implications ✓ Emergency management ✓ Evidence-based medicine Whenever discussing a disease or condition, correlate it with anaesthesia management. Whenever discussing drugs include: • Mechanism • Dose • Preparation • Onset • Duration • Metabolism • Elimination • Advantages • Disadvantages • Contraindications • Adverse effects • Monitoring • Recent advances Mention all important normal values. Mention important formulae. Mention all classifications. Mention all scoring systems. Mention all recent guidelines. Mention recent advances till 2026. Highlight commonly asked viva questions. Highlight "Exam Pearls." Highlight "High Yield Facts." Highlight "Must Remember." Mention important numerical values inside tables. Whenever possible provide simple ASCII flowcharts. Avoid unnecessary history unless specifically asked. Always mention practical anaesthesia relevance. The answer should appear like a topper's handwritten notes converted into text. I'm sharing with you a question bank pdf, segregate all questions system wise and write answer one question at a time strictly in the following MD Anaesthesiology university examination format. The answer should be examiner-oriented, highly structured, easy to revise, and capable of fetching 40–50 marks. GENERAL RULES • Use only headings, subheadings, bullet points, tables and flowcharts. • Avoid long paragraphs. • Present information from Basic → Advanced. • Emphasise important points in bold. • Include all important normal values, cut-offs, formulae, drug doses, classifications and guidelines. • Correlate every topic with anaesthesia, ICU and perioperative medicine wherever applicable. • Mention recent evidence and guidelines up to 2026. • Include practical clinical relevance throughout. ANSWER FORMAT 1. Title 2. Definition • Standard textbook definition • Alternative definitions (if applicable) 3. Introduction • Overview • Importance • Incidence/Epidemiology (if applicable) 4. Relevant Anatomy 5. Relevant Physiology 6. Relevant Pharmacology (if applicable) 7. Relevant Physics/Equipment (if applicable) 8. Pathophysiology • Mechanism • Flowchart 9. Classification • All standard classifications • Tables • Mnemonics (if available) 10. Etiology/Risk Factors 11. Clinical Features • Symptoms • Signs • Examination findings 12. Diagnosis • Clinical approach • Differential diagnosis • Diagnostic algorithm 13. Investigations • Routine • Special • Gold standard • Point-of-care tests 14. Important Normal Values • Present in a table 15. Important Formulae and Equations • Formula • Clinical significance 16. Monitoring • Clinical • Standard ASA monitoring • Advanced monitoring • Invasive monitoring • POCUS (where applicable) 17. Anaesthetic Considerations A. Preoperative B. Intraoperative C. Postoperative 18. Management • Conservative • Medical • Surgical • ICU management • Emergency management • Algorithms 19. Drugs For each important drug mention: • Class • Mechanism of action • Dose • Preparation • Onset • Duration • Metabolism • Elimination • Advantages • Disadvantages • Contraindications • Adverse effects • Monitoring 20. Complications • Early • Late • Anaesthesia-related 21. Recent Advances (2024–2026) 22. Current Guidelines • ASA • ESAIC • DAS • SCCM • ERAS • WHO • Other relevant society guidelines 23. Important Tables • Comparison tables • Advantages vs Disadvantages • Indications vs Contraindications • Differential diagnosis 24. Flowcharts and Algorithms • Diagnosis • Management • Decision-making pathways FORMATTING REQUIREMENTS • Use Heading → Subheading → Bullet hierarchy. • Prefer flowcharts over paragraphs. • Highlight keywords, drug doses, numerical values and classifications in bold. • Keep the language concise, scientific and examiner-friendly. • Write exactly as expected from a top-ranking MD Anaesthesiology postgraduate in university theory examinations.

Reading File
Running Command

cd /tmp/workspace/attachments/7823b878-a476-4198-8b9f-ad2921dd232d/ && python3 -c " import pdfplumber with pdfplumber.open('question bank MD.pdf') as pdf: print(f'Total pages: {len(pdf.pages)}') for i, page in enumerate(pdf.pages[:5]): text = page.extract_text() print(f'--- PAGE {i+1} ---') print(text) print() "

Running Command

cd /tmp/workspace/attachments/7823b878-a476-4198-8b9f-ad2921dd232d/ && python3 -c " import pdfplumber with pdfplumber.open('question bank MD.pdf') as pdf: for i, page in enumerate(pdf.pages[5:]): text = page.extract_text() print(f'--- PAGE {i+6} ---') print(text) print() "

I'll tell you when to start and after each question ask me if i would like to move on to the next question, use your algorithm to analyse which sets of questions are repeating or are similar or are overlapping and try to answer them together or at once. Avoid repeating questions. We will proceed question by question, one at a time. Let's keep the word limit to the answers to 500-600 words. Excluding the headings and the subheadings words. Do you have any suggestions?

Understood. Here are my suggestions before we begin:

Suggestions for This Session

1. Grouping Strategy After reviewing the full question bank, I have identified clear clusters of overlapping/repeating questions. I will:
  • Combine questions that are identical or near-identical (e.g., "Malignant hyperthermia" appears 3 times - answered once)
  • Combine questions that are subsets of each other (e.g., "TURP Syndrome" + "Signs, symptoms and management of TURP Syndrome" - answered together)
  • Keep case-based questions separate from pure topic questions even if the topic overlaps, since examiners expect different framing
2. Word Limit
  • 500-600 words of body content (excluding headings, subheadings, table headers, bullet lead-ins)
  • Tables and flowcharts are excluded from the word count
  • Drug doses, numerical values, and classifications will be in tables to save word budget
3. Format Per Answer
  • I will use only the relevant sections from the full format template - not all 24 sections for every question (saves space, improves readability)
  • Every answer will have: Definition → Key Physiology/Pathophysiology → Classification (if applicable) → Management → Anaesthetic Relevance → Exam Pearls
4. System-wise Order I suggest proceeding in this order (matches exam paper pattern):
  1. Monitoring
  2. Physics & Equipment
  3. Anaesthesia Machine
  4. Drugs (Inhalational → LA → IV agents → Muscle relaxants → Opioids → Cardiac drugs)
  5. Physiology (Cardiac → Respiratory → Neuro → Obstetric)
  6. Subspecialty Anaesthesia (Neuro → Cardiac → Thoracic → Obstetric → Paediatric → Ortho → Uro → Endocrine → Renal → Ophthalmic)
  7. Critical Care & ICU
  8. Pain
  9. Regional Anaesthesia
  10. Miscellaneous & Airway
5. One Suggestion from My End Since 500-600 words is tight for 40-50 mark answers, I recommend we treat each answer as a structured revision note - dense, high-yield, examiner-facing - rather than a full essay. This actually scores better in viva and theory both.

Whenever you say "Start" or "Begin", I will open with Question 1 from the first system (Monitoring) and wait for your go-ahead before each subsequent question.
Ready when you are.

I like your suggestion..

Thank you! Just say "Start" or "Begin" whenever you're ready, and we'll dive into Question 1.
I'll keep every answer sharp, structured, and examiner-ready. 🎯

So no word limit but we're also not compromising on quality of answers right ?

Exactly right.
No artificial word limit. Every answer will be:
  • As long as the topic demands - no padding, no cutting corners
  • Full 40-50 mark quality - the kind that makes an examiner nod and give full marks
  • Structured like a topper's notes - dense, crisp, high-yield, not wordy
The earlier 500-600 word suggestion was mine - happy to drop it entirely. Quality always wins over brevity in MD theory papers.
Ground rules going forward:
  • Long topics (e.g., Malignant Hyperthermia, ARDS, Difficult Airway) → full comprehensive answers
  • Short topics (e.g., Beer-Lambert Law, Coanda Effect) → concise but complete
  • Case-based questions → always include a structured anaesthetic plan
  • Every answer ends with Exam Pearls + Recent Advances
Just say "Start" and we begin. 🎯

Q1

Reading File
Finding Sources
Finding Sources
Reading File
Reading File

MONITORING IN ANAESTHESIA

Combined Answer: Invasive Monitoring | Advanced Hemodynamic Monitoring | Mandatory Monitoring During Anaesthesia

(Covers: Q1, Q2, Q3, Q4 from the Monitoring cluster)

1. MANDATORY MINIMUM MONITORING DURING ANAESTHESIA

ASA Basic Standards for Intraoperative Monitoring (2020, reaffirmed 2025)

Standard 1: Qualified anaesthesia personnel shall be present throughout the conduct of all general anaesthetics, regional anaesthetics, and monitored anaesthesia care.
Standard 2: During all anaesthetics, the patient's oxygenation, ventilation, circulation, and temperature shall be continually evaluated.
ParameterMonitor UsedMinimum Requirement
OxygenationPulse oximetry (SpO2)Mandatory
VentilationCapnography (EtCO2)Mandatory for GA
CirculationECG, NIBP, HRMandatory
TemperatureThermometerMandatory if significant change anticipated
Inspired O2O2 analyzer on circuitMandatory
Airway pressureAirway pressure alarmMandatory for ventilated patients
Exam Pearl: ASA mandates continual (repeated regularly) vs. continuous (uninterrupted) for some parameters. SpO2 and ECG are continuous; NIBP may be continual (every 5 min).

2. CLASSIFICATION OF MONITORING

MONITORING IN ANAESTHESIA
        |
        |-------- NON-INVASIVE
        |              |-- Clinical (look, listen, feel)
        |              |-- Standard (SpO2, ECG, NIBP, EtCO2, Temp)
        |              |-- Advanced non-invasive (BIS, NMT, TOE, USCOM, NI-CO)
        |
        |-------- INVASIVE
                       |-- Basic invasive (Arterial line, CVP)
                       |-- Advanced invasive (PAC, PICCO, LIDCO, IABP)

3. STANDARD (NON-INVASIVE) MONITORING

MonitorNormal ValueClinical Significance
SpO295-100%Detects hypoxaemia early
EtCO235-45 mmHgConfirms intubation, ventilation adequacy
ECGRate 60-100/minArrhythmia, ischaemia detection
NIBP<140/90 mmHgEvery 5 min minimum
Temperature36.5-37.5°CHypothermia/MH detection
Inspired O2 (FiO2)>0.21Anti-hypoxic device function

4. INVASIVE MONITORING - TYPES AND FEATURES

A. Arterial Line (Invasive Blood Pressure)

  • Sites (preference order): Radial > Femoral > Brachial > Dorsalis pedis > Ulnar
  • Indications:
    • Beat-to-beat BP monitoring in haemodynamically unstable patients
    • Frequent ABG sampling
    • Deliberate hypotension / major surgery
    • Patients on vasoactive drugs
  • Contraindications: Failed Allen's test, local infection, coagulopathy (relative)
  • Normal arterial waveform components:
Systolic peak → Dicrotic notch (aortic valve closure) → Diastolic runoff
ValueNormal Range
Systolic BP100-140 mmHg
Diastolic BP60-90 mmHg
Mean Arterial Pressure (MAP)70-105 mmHg
Pulse Pressure40-60 mmHg
Formula: MAP = DBP + 1/3 (SBP - DBP) = DBP + 1/3 PP
  • Whip artifact - over-damped vs under-damped waveforms
  • Must Remember: Allen's test mandatory before radial arterial cannulation

B. Central Venous Pressure (CVP)

  • Sites: Right IJV (preferred) > Subclavian > Femoral > Left IJV
  • Normal CVP: 2-8 mmHg (or 5-12 cmH2O)
  • Waveform components:
WaveRepresents
aAtrial contraction
cTricuspid valve closure
vVenous filling against closed valve
x descentAtrial relaxation
y descentTricuspid valve opening
  • High CVP causes: Cardiac tamponade, RHF, fluid overload, PEEP, pneumothorax
  • Low CVP causes: Hypovolaemia, vasodilation, sepsis
  • Limitation: CVP is a poor predictor of fluid responsiveness (Marik, Chest 2008) - should NOT be used alone to guide fluid therapy
Exam Pearl: Cannon 'a' waves = complete heart block / nodal rhythm. Giant 'v' waves = tricuspid regurgitation.

C. Pulmonary Artery Catheter (PAC) / Swan-Ganz Catheter

  • Indications: Complex cardiac surgery, ARDS, refractory shock, cardiac transplant
  • Parameters measured:
ParameterNormal Value
CVP / RAP2-8 mmHg
RV pressure25/5 mmHg
PA systolic/diastolic25/10 mmHg
PCWP (wedge)6-12 mmHg
Cardiac Output (CO)4-8 L/min
Cardiac Index (CI)2.5-4.0 L/min/m²
SVR800-1200 dynes/sec/cm⁵
PVR100-250 dynes/sec/cm⁵
SvO265-75%
  • Complications: Arrhythmias, PA rupture, infection, knotting, pulmonary infarction
  • Current evidence: PAC use has significantly declined - large RCTs (ESCAPE, PAC-Man) showed no mortality benefit in most ICU populations

5. ADVANCED HEMODYNAMIC MONITORING

A. Pulse Contour Cardiac Output (PiCCO)

  • Combines transpulmonary thermodilution + pulse contour analysis
  • Requires: femoral/axillary arterial line + central venous line
  • Additional parameters:
    • ITBV (Intrathoracic Blood Volume) - better preload indicator than CVP
    • EVLW (Extravascular Lung Water) - pulmonary oedema quantification
    • SVV (Stroke Volume Variation) - fluid responsiveness
  • SVV >13% = likely fluid responder (valid only in sinus rhythm, controlled ventilation)

B. LiDCO (Lithium Dilution Cardiac Output)

  • Uses lithium indicator dilution + pulse power analysis
  • Less invasive than PAC - requires only peripheral arterial + venous access
  • Contraindication: Patients on lithium therapy, first trimester pregnancy

C. Oesophageal Doppler Monitor (ODM/CardioQ)

  • Measures descending aortic blood flow velocity
  • FTc (Corrected Flow Time): Normal >330 ms - guides fluid therapy
  • Non-invasive, real-time CO monitoring
  • NICE approved for high-risk surgical patients

D. USCOM (Ultrasound Cardiac Output Monitor)

  • Completely non-invasive
  • Doppler US of aortic or pulmonary outflow tract
  • Portable, bedside use

E. FloTrac/Vigileo

  • Arterial waveform analysis without calibration
  • Auto-calculates SVV, CO, CI from standard arterial line
  • Less accurate in states of high vasopressor requirements

F. NI-CO (Non-Invasive Cardiac Output)

  • Based on partial CO2 rebreathing technique (Fick principle)
  • Formula: CO = VCO2 / CvCO2 - CaCO2

6. DYNAMIC INDICES OF FLUID RESPONSIVENESS

IndexThresholdAdvantage
PPV (Pulse Pressure Variation)>13%Gold standard for mechanically ventilated
SVV (Stroke Volume Variation)>13%Reliable in controlled ventilation
SPV (Systolic Pressure Variation)>10 mmHgSimple, from arterial line
PLR (Passive Leg Raise)>10% CO increaseWorks in spontaneous breathing
IVC Collapsibility (POCUS)>50% (spontaneous)Non-invasive, bedside
Must Remember: Dynamic indices (PPV, SVV) are valid only in:
  • Sinus rhythm
  • Fully controlled mechanical ventilation
  • Tidal volume ≥ 8 mL/kg
  • No right heart failure

7. NEUROMONITORING & DEPTH OF ANAESTHESIA

MonitorParameterNormal/Target
BISDepth of anaesthesia40-60 (GA)
EntropyState/Response Entropy40-60
NarcotrendEEG-based DoAStage D-E
SSEP/MEPSpinal cord integrityBaseline preservation

8. NEUROMUSCULAR MONITORING

ModeClinical Use
TOF (Train of Four)Degree of NMB, reversal adequacy
PTC (Post-Tetanic Count)Deep block monitoring
DBS (Double Burst Stimulation)Residual block detection
TOF ratio >0.9 = Adequate reversal

9. POINT-OF-CARE MONITORING (POCUS in OT/ICU)

  • Cardiac POCUS: LV/RV function, pericardial effusion, volume status
  • Lung POCUS: Pneumothorax (loss of lung sliding), B-lines (pulmonary oedema)
  • Vascular POCUS: DVT, IVC diameter for preload assessment
  • FAST exam: Trauma abdominal free fluid

10. IMPORTANT FORMULAE

FormulaValue
MAP = DBP + 1/3(SBP-DBP)Target >65 mmHg in sepsis
CO = HR × SVNormal 4-8 L/min
CI = CO / BSANormal 2.5-4.0 L/min/m²
SVR = (MAP-CVP) × 80 / CONormal 800-1200 dyn·s·cm⁻⁵
DO2 = CO × CaO2 × 10Normal 520-570 mL/min/m²
VO2 = CO × (CaO2-CvO2) × 10Normal 110-160 mL/min/m²
O2ER = VO2/DO2Normal 22-30%

11. RECENT ADVANCES (2024-2026)

  • EV1000/HemoSphere platform: integrates multiple haemodynamic parameters on single screen
  • Minimally invasive CO monitoring now preferred over PAC in most centres
  • AI-based haemodynamic prediction (e.g., Edwards Acumen IQ): predicts hypotension up to 15 min in advance using arterial waveform analysis
  • Masimo Root with noninvasive haemoglobin (SpHb) monitoring - reduces unnecessary transfusions
  • POCUS integration into standard monitoring - ESAIC 2024 guidelines recommend POCUS competency for all anaesthesiologists

12. CURRENT GUIDELINES

  • ASA (2020, reaffirmed 2025): Basic monitoring standards - SpO2, EtCO2, ECG, NIBP, Temp mandatory
  • ESAIC (2023): Recommends goal-directed haemodynamic therapy using dynamic indices (PPV/SVV) over static (CVP/PCWP) for high-risk surgery
  • SCCM/ESICM (2021): Surviving Sepsis Campaign - MAP ≥65 mmHg target; CO-guided resuscitation in refractory shock
  • NICE (UK): Oesophageal Doppler monitoring for all major abdominal surgery

📌 EXAM PEARLS

  1. SpO2 detects desaturation LATE - it lags behind true PaO2 by 30-60 seconds due to the oxyhaemoglobin dissociation curve
  2. CVP is NOT a reliable indicator of fluid responsiveness - this is one of the most tested statements in modern anaesthesia exams
  3. PPV >13% in fully ventilated patient = fluid responder - cornerstone of goal-directed therapy
  4. PAC use has declined due to lack of mortality benefit in RCTs - know the complications
  5. Allen's test must be documented before radial arterial line insertion
  6. BIS 40-60 for GA; BIS <40 = burst suppression; BIS >60 = awareness risk

🔴 HIGH YIELD FACTS

  • PCWP >18 mmHg = cardiogenic pulmonary oedema
  • SvO2 <65% = increased O2 extraction (shock, anaemia, sepsis)
  • ScvO2 (from CVC in SVC) is ~5-8% higher than true SvO2
  • IVC diameter >2 cm + <50% collapsibility = fluid non-responder
  • Oesophageal Doppler FTc <330 ms = hypovolaemia; >400 ms = vasodilation

References: Miller's Anesthesia 10e, Ch. 49; Barash Clinical Anesthesia 9e, Ch. 26; Morgan & Mikhail Clinical Anesthesiology 7e; Marino's ICU Book 4e; ASA Standards 2020

Would you like to move on to the next question?

Q2

Finding Sources
Finding Sources
Reading File
Reading File
Reading File

PULSE OXIMETRY AND BEER-LAMBERT LAW

Combined Answer: Pulse Oximetry (×5) | Beer-Lambert Law (×2)


1. DEFINITION

  • Pulse Oximetry: A non-invasive, continuous method of measuring functional oxygen saturation of arterial haemoglobin (SpO2) using differential light absorption at two wavelengths, exploiting the pulsatile nature of arterial blood flow
  • SpO2 = peripheral (pulse oximeter) estimate of SaO2 (true arterial O2 saturation from ABG)

2. BEER-LAMBERT LAW - THE PHYSICAL BASIS

Statement

"The absorbance of light by a substance is directly proportional to its concentration and the path length through which light travels."

Mathematical Expression

A = ε · b · c
SymbolMeaningUnits
AAbsorbance (= -log T = log P₀/P)Dimensionless
εMolar absorptivity / extinction coefficientL·mol⁻¹·cm⁻¹
bPath lengthcm
cConcentration of absorbing speciesmol/L
TTransmittance (P/P₀)Dimensionless

Additional Relationships

  • A = 2 - log %T
  • A = -log T
  • Absorbance and transmittance are inversely related
  • Law is valid only for monochromatic radiation and dilute solutions

Deviations from Beer-Lambert Law

  • High concentrations (non-linear at A > 2.0)
  • Polychromatic light sources
  • Changes in pH, ionic strength, temperature
  • Scattering substances (lipids, turbid solutions)
  • Clinical relevance: SpO2 inaccurate in dyshemoglobinaemias (COHb, MetHb) - these deviate from expected absorbance ratios

3. PRINCIPLE OF PULSE OXIMETRY

Key Concept: AC/DC Signal Separation

LIGHT ABSORBED BY TISSUE
         |
         |--- DC component (steady/non-pulsatile)
         |        = venous blood + tissue + bone + pigment
         |
         |--- AC component (pulsatile)
                  = ARTERIAL BLOOD ONLY
                       |
                  This is what pulse oximeter measures
  • Two wavelengths used:
    • 660 nm (RED): Deoxy-Hb absorbs more
    • 940 nm (INFRARED): Oxy-Hb absorbs more

The R Ratio (Heart of Pulse Oximetry)

$$R = \frac{AC_{660}/DC_{660}}{AC_{940}/DC_{940}}$$
R ValueSpO2 (approx.)
R = 0.4SpO2 ≈ 100%
R = 1.0SpO2 ≈ 85%
R > 2.0SpO2 ≈ 0%
  • R is matched against an internal empirical calibration curve built from healthy volunteer data (SpO2 70-100%)
  • Accuracy: ±2-3% in SpO2 range 70-100%
  • NOT validated below SpO2 of 70% - extrapolated data only

4. COMPONENTS OF PULSE OXIMETER

PULSE OXIMETER PROBE
      |
      |-- Light Emitter (2 LEDs: 660nm + 940nm, alternating)
      |-- Photodetector (opposite side = transmission; same side = reflectance)
      |-- Ambient light cancellation (both LEDs off = ambient baseline)
TypeProbe PlacementAdvantage
TransmissionFinger, toe, ear lobeStandard, most common
ReflectanceForehead, nasal septumNo pulsatile tissue needed, better in poor perfusion

5. ISOBESTIC POINT

  • Definition: Wavelength at which OxyHb and DeoxyHb have equal absorbance
  • Value: 805 nm (also 590 nm)
  • At this wavelength, absorbance is independent of O2 saturation
  • Used as a reference point in co-oximetry
  • Exam Pearl: Pulse oximetry uses 660 nm and 940 nm - NOT the isobestic point (this is important!)

6. MULTIWAVELENGTH / CO-OXIMETRY

  • Standard pulse oximeter uses 2 wavelengths - measures only functional saturation
  • Co-oximeter uses up to 12 wavelengths - measures:
    • OxyHb (O2Hb)
    • DeoxyHb (HHb)
    • Carboxyhaemoglobin (COHb)
    • Methaemoglobin (MetHb)
    • Sulphhaemoglobin (SulfHb)
    • Total Hb (SpHb) - Masimo Rainbow technology

Functional vs Fractional Saturation

TermFormulaMeasured by
Functional SaO2O2Hb / (O2Hb + HHb) × 100Standard pulse oximeter
Fractional SaO2O2Hb / Total Hb × 100Co-oximeter / ABG
Must Remember: Standard pulse oximeter gives falsely HIGH SpO2 in COHb poisoning because COHb absorbs at 660 nm similarly to OxyHb!

7. CAUSES OF INACCURATE SpO2

Falsely HIGH SpO2

CauseMechanism
Carbon monoxide poisoning (COHb)COHb reads as OxyHb at 660 nm - SpO2 reads ~99% even when patient is hypoxic
Calibration below 70%Extrapolated, not validated data

Falsely LOW SpO2

CauseMechanism
MethaemoglobinaemiaMetHb absorbs equally at 660 & 940 nm; R→1; SpO2 drifts toward 85% regardless of true SaO2
Intravenous dyesMethylene blue, indocyanine green, indigo carmine
Nail polish (dark colours - blue, green, black)Absorbs at 660 nm
Severe anaemia (Hb < 5 g/dL)Insufficient signal
Peripheral vasoconstriction / hypothermiaReduced pulsatile signal
Venous pulsationTricuspid regurgitation, external compression of probe
Motion artifactCommonest cause of false alarm in PACU/ICU
Ambient light interferenceFluorescent, fibreoptic lights, bilirubin lamps
Dark skin pigmentationMay underread SpO2 - IMPORTANT post-COVID equity concern
High Yield Fact: In MetHb toxicity, SpO2 plateaus at ~85% regardless of actual saturation - hallmark finding.

8. PLETHYSMOGRAPHIC WAVEFORM (PPG)

  • Pulse oximeter also functions as a photoplethysmograph
  • Waveform variations (PVI - Pleth Variability Index) can predict fluid responsiveness
  • PVI >13-14% = likely fluid responder in mechanically ventilated patients
  • Perfusion Index (PI) from waveform amplitude = surrogate for peripheral perfusion

9. CLINICAL APPLICATIONS IN ANAESTHESIA

SettingUse
IntraoperativeContinuous SpO2, early hypoxaemia detection
Recovery roomPost-extubation monitoring, opioid-induced respiratory depression
ICUContinuous monitoring, ventilator weaning
OPD/PACBaseline SpO2, exercise desaturation testing
NeonatalCritical CHD screening (right hand + foot)
Fibreoptic intubationMonitoring during awake intubation
Fluid responsivenessPVI from plethysmographic waveform

10. LIMITATIONS OF PULSE OXIMETRY

  • Detects hypoxaemia late (lag 30-90 seconds behind true PaO2 fall)
  • Cannot detect hyperoxia (no upper alarm once SpO2 = 100%)
  • Cannot assess ventilation (CO2 retention undetected - need EtCO2)
  • Poor signal in states of low perfusion
  • Cannot replace ABG for acid-base, CO2, and precise PaO2 measurement

11. IMPORTANT NORMAL VALUES

ParameterNormal Value
SpO295-100%
SaO295-100%
PaO280-100 mmHg
PaO2 on 100% O2>600 mmHg
COHb (non-smokers)<1.5%
COHb (smokers)up to 10%
MetHb (normal)<1%
SpO2 at which cyanosis appears~85%

12. PHYSICS SUMMARY TABLE

PrincipleApplication in Pulse Oximetry
Beer-Lambert LawAbsorbance ∝ concentration × path length
Isobestic point (805 nm)Reference for co-oximetry
Lambert's LawAbsorbance ∝ path length
Beer's LawAbsorbance ∝ concentration
R ratioConverts absorbance ratio to SpO2 via calibration curve

13. RECENT ADVANCES (2024-2026)

  • Masimo Rainbow SET technology: SpHb (non-invasive Hb), SpCO, SpMet, SpO2 from single probe
  • Equity concern: Multiple studies (2020-2024) showed pulse oximeters overestimate SpO2 in darker skin tones - FDA issued guidance for improved testing across skin tones (2024)
  • Wearable continuous SpO2 monitoring (smartwatches, patches) - now entering perioperative pathways
  • AI-driven waveform analysis: SpO2 waveform used for non-invasive blood pressure estimation

📌 EXAM PEARLS

  1. Beer-Lambert Law: A = ε·b·c - must be written with all symbols defined
  2. Two wavelengths: 660 nm (RED) and 940 nm (IR) - know which haemoglobin absorbs more at each
  3. COHb → falsely HIGH SpO2 | MetHb → SpO2 plateaus at 85% - most common viva traps
  4. Isobestic point = 805 nm - where OxyHb and DeoxyHb absorb equally
  5. Pulse oximeter calibrated in healthy volunteers at SpO2 70-100% - not valid below 70%
  6. Cannot detect CO2 retention - always pair with EtCO2 or ABG

🔴 HIGH YIELD FACTS

  • SpO2 lags PaO2 by 30-90 seconds - critical during rapid desaturation
  • Standard oximeter = 2 wavelengths (functional SpO2); Co-oximeter = up to 12 wavelengths (fractional saturation)
  • Methylene blue (used in methHb treatment) transiently drops SpO2 to ~65% - do not panic
  • PVI >13% from plethysmograph = fluid responsiveness predictor
  • FDA accuracy requirement: SpO2 ≤ ±3% root mean square difference

References: Miller's Anesthesia 10e, Ch. 37; Morgan & Mikhail Clinical Anesthesiology 7e; Henry's Clinical Diagnosis & Management by Laboratory Methods; Barash Clinical Anesthesia 9e

Would you like to move on to the next question?

Q3

Finding Sources
Finding Sources
Reading File
Reading File
Reading File

MIXED VENOUS OXIMETRY (SvO2) AND JUGULAR VENOUS OXYGEN SATURATION (SjvO2)

Combined Answer: Mixed Venous Oximetry | Jugular Venous Oxygen Saturation | SvO2 Conditions Decreased


1. DEFINITIONS

  • SvO2 (Mixed Venous Oxygen Saturation): O2 saturation of blood in the proximal pulmonary artery - represents the average O2 saturation of blood returning from the entire body to the right heart, weighted by regional blood flows
  • ScvO2 (Central Venous O2 Saturation): O2 saturation of blood from the superior vena cava via a central venous catheter - a clinically practical surrogate for SvO2
  • SjvO2 (Jugular Venous O2 Saturation): O2 saturation at the jugular bulb - reflects global cerebral O2 supply-demand balance

2. PHYSIOLOGICAL BASIS - THE FICK PRINCIPLE

Fick's Equation

VO2 = CO × (CaO2 - CvO2) × 10
Rearranging to solve for SvO2:
SvO2 = SaO2 - VO2 / (1.34 × Hb × CO)

Derivation: SvO2 and O2 Extraction Ratio

RelationshipFormula
O2 Extraction RatioERO2 = VO2 / DO2
Simplified (when SaO2 ≈ 1)SvO2 = 1 - ERO2
DO2 (O2 Delivery)CO × CaO2 × 10
Key concept: SvO2 is the mirror of O2 extraction ratio. When the body extracts more O2 (ERO2↑), SvO2 falls. When delivery improves, SvO2 rises.

3. DETERMINANTS OF SvO2

SvO2 = SaO2 - VO2 / (1.34 × Hb × CO)

SvO2 is DECREASED by:              SvO2 is INCREASED by:
  |                                   |
  |-- ↓ SaO2 (hypoxaemia)             |-- ↑ SaO2 (O2 therapy)
  |-- ↓ Hb (anaemia)                  |-- ↑ Hb (transfusion)
  |-- ↓ CO (cardiogenic shock)        |-- ↑ CO (sepsis, vasodilatory)
  |-- ↑ VO2 (fever, shivering,        |-- ↓ VO2 (hypothermia,
       seizures, pain, sepsis)              sedation, anaesthesia)
                                      |-- Tissue O2 extraction failure
                                           (late sepsis, cyanide toxicity)

4. NORMAL VALUES

ParameterNormal ValueClinical Threshold
SvO265-75%<50% = severe tissue hypoxia
ScvO270-80%<65% = tissue O2 debt
PvO240 mmHg<28 mmHg = anaerobic metabolism
O2ER (normal)22-30%>50% = critical O2 extraction
SjvO255-75%<50% = cerebral ischaemia; >75% = hyperaemia/luxury perfusion
Must Remember: ScvO2 is normally 2-5% HIGHER than SvO2 (under normal conditions). During shock/haemodynamic instability, this relationship reverses and the gap widens.

5. CAUSES OF DECREASED SvO2

A. Decreased O2 Delivery (DO2↓)

CategorySpecific Causes
Low SaO2Hypoxaemia, hypoventilation, V/Q mismatch, diffusion defect
Low HbAcute blood loss, haemolysis, anaemia
Low COCardiogenic shock, cardiac tamponade, massive PE, severe hypovolaemia

B. Increased O2 Consumption (VO2↑)

CauseMechanism
Fever / Sepsis↑ metabolic rate
ShiveringMuscle work
Pain / AnxietySympathetic activation
Seizures↑ cerebral metabolic rate
Thyrotoxicosis↑ basal metabolic rate
Malignant hyperthermiaHypermetabolism
Burns↑ catecholamines, healing

6. CAUSES OF FALSELY HIGH SvO2 (IMPORTANT TRAPS)

CauseWhy SvO2 is High Despite Tissue Hypoxia
Late/severe sepsisMitochondrial dysfunction → tissue cannot extract O2
Cyanide poisoningBlocks cytochrome oxidase → O2 not utilised
Wedged PACSamples arterialized pulmonary capillary blood
Left-to-right shuntOxygenated arterial blood mixes in right heart
Hypothermia↓ VO2 dramatically
Exam Pearl: Normal/high SvO2 does NOT rule out tissue hypoxia - especially in septic shock (microcirculatory failure) and cyanide poisoning. Always correlate with serum lactate.

7. MEASUREMENT OF SvO2

Direct Method

  • Pulmonary Artery Catheter (PAC):
    • Fibreoptic PAC (e.g., Vigilance, Oximetrix) - continuous SvO2
    • Intermittent blood sampling from distal (PA) port of PAC - spot SvO2
    • Gold standard

Surrogate Method

  • ScvO2 from CVC in SVC - widely used in clinical practice
  • Rivers et al. (EGDT, NEJM 2001): ScvO2 ≥70% as resuscitation target in septic shock
  • Surviving Sepsis Campaign 2021: ScvO2 ≥70% is still used as a guide (though ARISE, ProCESS, ProMISe trials questioned protocolized EGDT)

8. CLINICAL APPLICATIONS IN ANAESTHESIA & ICU

ApplicationSvO2 Target
Septic shock resuscitationScvO2 ≥70% (SSC 2021)
Cardiac surgery / CPBSvO2 ≥65% during bypass
ARDS managementSvO2 to guide O2 delivery strategy
Weaning from ventilatorSvO2 <50% during SBT = weaning failure predicted
High-risk surgeryGoal-directed therapy to maintain SvO2 ≥65%
Haemodynamic optimizationLow SvO2 = DO2 inadequate → increase CO/Hb/SaO2

9. JUGULAR VENOUS OXYGEN SATURATION (SjvO2) - CEREBRAL MONITORING

Principle

  • Measures global cerebral O2 supply-demand balance
  • Cerebral O2 Extraction = (SaO2 - SjvO2)
  • Normal CMRO2 (cerebral metabolic rate for O2) = 3-5 mL/100g/min

Technique

  • Retrograde catheterisation of internal jugular vein
  • Catheter tip placed in jugular bulb (C1-C2 level) - confirmed by X-ray
  • Usually the dominant jugular vein (right in most patients) is cannulated
  • Right jugular drains predominantly cortical blood
  • Left jugular drains more subcortical regions

Normal Values and Interpretation

SjvO2InterpretationAction
55-75%Normal cerebral oxygenationContinue
<50%Cerebral ischaemia - global↑ CPP, ↑ DO2, ↓ CMRO2
<40%Critical ischaemiaUrgent intervention
>75%Cerebral hyperaemia OR luxury perfusion OR deathReduce CBF if hyperaemia
>85%Neuronal death / brain death

Indications for SjvO2 Monitoring

  • Traumatic Brain Injury (TBI) - severe head injury
  • Neurosurgery with risk of cerebral ischaemia
  • Carotid endarterectomy (during cross-clamping)
  • Cardiac surgery with circulatory arrest
  • SAH and vasospasm monitoring

Causes of Desaturation (SjvO2 < 50%)

  • Hypocapnia (hyperventilation → cerebral vasoconstriction)
  • Arterial hypotension → ↓ CPP
  • Anaemia
  • Hypoxaemia
  • ↑ CMRO2 (fever, seizures, pain)
  • Raised ICP with reduced CPP

Causes of High SjvO2 (>75%)

  • Cerebral hyperaemia (e.g., post-hyperventilation rebound)
  • Brain death (no O2 consumption → 100%)
  • AV malformations (arteriovenous shunting)
  • Hypothermia

Limitations

  • Global monitor only - focal ischaemia may be missed
  • Incomplete intracranial mixing (left ≠ right)
  • Extracranial contamination if tip too low (facial vein admixture)
  • Requires skilled placement + fluoroscopic confirmation

10. CEREBRAL OXIMETRY (rSO2) - NON-INVASIVE ALTERNATIVE

  • NIRS (Near-Infrared Spectroscopy) based
  • Measures regional cerebral O2 saturation (rSO2) non-invasively
  • Sensors placed on forehead (bifrontal)
  • Normal rSO2: 60-80% (reflects mixed arterio-venous saturation ~25:75 ratio)
  • rSO2 <50% or >20% fall from baseline = intervention threshold
  • Used in: cardiac surgery, carotid surgery, beach-chair shoulder surgery

11. COMPARISON TABLE: SvO2 vs ScvO2 vs SjvO2

FeatureSvO2ScvO2SjvO2
SitePulmonary arterySVC / CVCJugular bulb
What it reflectsGlobal whole-body O2 balanceUpper body O2 balanceCerebral O2 balance
Normal value65-75%70-80%55-75%
AccessPAC (invasive)CVC (less invasive)Retrograde IJV cannulation
Clinical useICU, cardiac surgerySepsis resuscitationNeuro ICU, TBI, cardiac surgery
Ischaemia threshold<50%<65%<50%

12. IMPORTANT FORMULAE

FormulaClinical Use
SvO2 = SaO2 - VO2 / (1.34 × Hb × CO)Determinants of SvO2
DO2 = CO × CaO2 × 10O2 delivery
VO2 = CO × (CaO2 - CvO2) × 10O2 consumption
ERO2 = VO2 / DO2 = 1 - SvO2O2 extraction ratio
CMRO2 = CBF × (CaO2 - CjvO2)Cerebral metabolic rate

13. ANAESTHETIC IMPLICATIONS

Intraoperative

  • Falling SvO2 during anaesthesia signals:
    • Inadequate depth (↑ VO2 due to stress)
    • Hypovolaemia (↓ CO)
    • Anaemia (↓ O2 carrying capacity)
    • Hypoxaemia (check SpO2/FiO2)
  • Target-directed fluid and inotrope therapy guided by SvO2/ScvO2

ICU

  • Low SvO2 + high lactate = serious tissue hypoxia - initiate goal-directed therapy
  • Normal SvO2 + high lactate = microcirculatory failure (late sepsis) or cyanide toxicity

14. RECENT ADVANCES (2024-2026)

  • Continuous non-invasive SvO2 estimation from multiwavelength pulse oximetry (experimental)
  • NIRS-guided cerebral protection during cardiac surgery becoming standard at high-volume centres
  • Integration of SjvO2 / rSO2 into multimodal neuromonitoring bundles for TBI (BTF 2024 update)
  • Growing evidence that ScvO2 > 70% as sole endpoint in sepsis is insufficient - lactate clearance ≥10% is now co-endorsed by SSC 2021

📌 EXAM PEARLS

  1. SvO2 = 1 - ERO2 - fundamental relationship, always derive this in exams
  2. ScvO2 > SvO2 by 2-5% under normal conditions; this reverses in shock
  3. SjvO2 < 50% = cerebral ischaemia; >75% = hyperaemia or brain death
  4. Normal/high SvO2 in sepsis does NOT mean adequate tissue oxygenation - mitochondrial dysfunction
  5. Wedged PAC gives falsely high SvO2 (sampling arterialized blood)
  6. Rivers' EGDT (2001) - ScvO2 ≥70% landmark trial - know its limitations (ARISE/ProCESS 2014)

🔴 HIGH YIELD FACTS

  • PvO2 normal = 40 mmHg | SvO2 normal = 65-75%
  • SjvO2 normal = 55-75% | rSO2 (NIRS) normal = 60-80%
  • Cyanide toxicity: SvO2 is HIGH (paradoxically), lactate is HIGH - classic exam question
  • Brain death: SjvO2 approaches 100% (no cerebral O2 consumption)
  • In septic shock: ScvO2 target ≥70% + lactate clearance ≥10% in 2 hours (SSC 2021)

References: Miller's Anesthesia 10e, Ch. 37, Ch. 35; Marino's ICU Book 4e; Morgan & Mikhail Clinical Anesthesiology 7e; Surviving Sepsis Campaign Guidelines 2021

Would you like to move on to the next question?

Next

Finding Sources
Finding Sources
Reading File
Reading File

END-TIDAL CO2, CAPNOGRAPHY AND CAPNOMETRY

Combined Answer: EtCO2 | Use of Capnography in Anaesthesia | Capnometry


1. DEFINITIONS

TermDefinition
CapnometryMeasurement and numeric display of CO2 concentration in respiratory gases
CapnographyMeasurement + waveform display (graphical tracing) of CO2 vs. time or vs. tidal volume
CapnogramThe actual waveform produced
EtCO2End-tidal CO2 - the CO2 concentration at the end of a normal expiration; approximates alveolar PCO2
Distinction: Capnometry = number only; Capnography = number + waveform. Clinically, capnography is always preferred.

2. PHYSICAL PRINCIPLE

  • Based on Beer-Lambert Law: CO2 absorbs infrared (IR) light at wavelength 4.26 μm
  • The amount of IR absorbed is proportional to CO2 concentration in the sample
  • Reference cell (CO2-free) compared with sample cell to calculate CO2 %

3. TYPES OF CAPNOGRAPHS

FeatureMainstream (Non-diverting)Sidestream (Diverting)
Sensor locationIn-line on airway (between ETT and circuit)Sample gas aspirated to monitor
Aspiration rateNone50-250 mL/min
Response timeFastestSlight delay (lag time)
Size/weightHeavy sensor on airwayLightweight airway adaptor
Water interferenceLessMore (water trap needed)
Use without ETTDifficultYes (nasal cannula, mask)
Paediatric useAdds dead spacePreferred
Contamination riskNoneScavenging needed
Exam Pearl: Sidestream preferred in paediatrics, MAC, non-intubated patients. Mainstream preferred in ventilated adult patients where response time matters.

4. THE NORMAL CAPNOGRAM - PHASES

CO2
(mmHg)
  40 ┤         ___________D (Plateau = EtCO2)
     |        /            \
     |       /C             \
     |      /                \
   0 ┤_____/A  B              \___E___
     |
     └──────────────────────────────── Time
         EXPIRATION          INSPIRATION
PhaseLetterRepresents
Phase I (A-B)BaselineAnatomical dead space gas - no CO2
Phase II (B-C)RisingMixture of dead space + alveolar gas
Phase III (C-D)Alveolar plateauPure alveolar gas - alpha angle at C-D junction
DPeak = EtCO2End-tidal CO2 value read here
Phase 0 (D-E)DownstrokeFresh gas inspiration - rapid CO2 fall
  • Alpha angle (between Phase II and III): Normal ≈ 100-110°; increases in obstructive disease
  • Beta angle (between Phase III and downstroke): Normal ≈ 90°; increases with rebreathing

5. NORMAL VALUES

ParameterNormal Value
EtCO235-45 mmHg (4.5-6.0%)
PaCO235-45 mmHg
PaCO2 - EtCO2 gradient (a-ET CO2 gap)2-5 mmHg
Respiratory rate (adults)12-16 breaths/min
Normal ETCO2 during CPR>10 mmHg = adequate compressions
Key Formula: PaCO2 = EtCO2 + Dead Space Component Increased dead space → increased (PaCO2 - EtCO2) gradient

6. THE PaCO2 - EtCO2 GRADIENT

Normal gradient = 2-5 mmHg (EtCO2 is always slightly LOWER than PaCO2 because of dilution by dead space)

Causes of INCREASED Gradient (EtCO2 ↓↓ relative to PaCO2)

  • Pulmonary embolism (↑ alveolar dead space - classic)
  • Air embolism (venous air embolism)
  • ↓ Cardiac output (any cause - reduced lung perfusion)
  • Hypotension
  • Severe COPD / emphysema (V/Q mismatch)
  • Low tidal volume / high RR ventilation

Causes of DECREASED Gradient (EtCO2 ≈ PaCO2 or > PaCO2)

  • ARDS / Pulmonary oedema (shunt physiology - venous admixture raises EtCO2)
  • Possible in pregnancy (↑ CO, ↓ dead space)

7. CAUSES OF ABNORMAL CAPNOGRAMS

A. Elevated EtCO2

CauseMechanism
Hypoventilation↓ CO2 elimination
Malignant Hyperthermia↑↑ CO2 production (earliest sign)
Rebreathing (exhausted soda lime)CO2 in inspired gas - baseline rises
Laparoscopy (CO2 pneumoperitoneum)Absorbed CO2
Thyrotoxicosis, fever, shivering↑ metabolic rate
↑ Cardiac output↑ CO2 delivery to lungs
Bicarbonate administrationCO2 liberation

B. Decreased EtCO2

CauseMechanism
Hyperventilation↑ CO2 elimination
Pulmonary embolism↑ dead space
Cardiac arrestNo circulation, no CO2 delivery
Circuit disconnectionSudden drop to zero
Oesophageal intubationNo CO2 waveform (after a few breaths)
Air embolism↑ dead space + ↓ CO

C. Characteristic Waveform Changes

Waveform PatternCause
Upward slanting plateau (shark fin)Bronchospasm / COPD - uneven emptying
Curare cleft (notch in plateau)Spontaneous respiratory effort against ventilator
Elevated baselineRebreathing / exhausted CO2 absorbent
Sudden drop to zeroCircuit disconnection, apnoea, extubation
Gradual decline↓ Cardiac output, worsening PE
Cardiac oscillations on waveformCardiogenic oscillations at end of expiration

8. CLINICAL USES OF CAPNOGRAPHY IN ANAESTHESIA

A. Confirmation of Tracheal Intubation

  • Most reliable bedside test for confirming ETT placement
  • Persistent waveform = tracheal intubation
  • Absent or rapidly disappearing waveform = oesophageal intubation
  • Does NOT detect right mainstem bronchial intubation (both lungs may still have CO2)
  • Gold standard remains direct visualisation + fibreoptic confirmation

B. Monitoring Ventilation Adequacy

  • Real-time CO2 elimination monitoring
  • Guide to ventilator settings (RR, TV)
  • Prevents inadvertent hyperventilation (especially in TBI patients where ETCO2 target = 35-40 mmHg)
  • In TBI/raised ICP: target EtCO2 35-40 mmHg (avoid hypocapnia unless cerebral herniation)

C. Monitoring During CPR

  • EtCO2 > 10 mmHg = adequate chest compressions
  • EtCO2 > 40 mmHg = predictor of ROSC (Return of Spontaneous Circulation)
  • EtCO2 < 10 mmHg after 20 min of ACLS = poor prognostic sign (AHA 2020)

D. Detection of Air/Gas Embolism

  • Rapid fall in EtCO2 = early sign of venous air embolism
  • Classic in sitting position neurosurgery, laparoscopy, liver surgery

E. Malignant Hyperthermia

  • Earliest monitor to show change - EtCO2 rises rapidly before temperature
  • Should trigger immediate action

F. Weaning from Mechanical Ventilation

  • EtCO2 trend during spontaneous breathing trial (SBT)
  • Rising EtCO2 during SBT = ventilatory failure / weaning failure

G. Assessment of Dead Space

Bohr's Equation: $$V_D/V_T = (PaCO_2 - P\bar{E}CO_2) / PaCO_2$$
Where P̄ECO2 = mean expired CO2
  • Normal VD/VT = 0.3 (30%)

H. Volumetric Capnography (CO2 vs Volume)

  • EtCO2 plotted against tidal volume (not time)
  • Calculates dead space more accurately (Enghoff modification of Bohr equation)
  • Allows PEEP optimisation and alveolar recruitment assessment

9. CAPNOGRAPHY IN SPECIAL SITUATIONS

SituationEtCO2 FindingSignificance
Laparoscopic surgeryGradual rise in EtCO2CO2 absorption from peritoneum
One-lung ventilationEtCO2 may ↑↓ ventilated alveolar surface
Prone positionEtCO2 may changeAltered V/Q - monitor closely
PregnancyLower EtCO2 (30-32 mmHg)Physiological hyperventilation
PaediatricsHigher RR, use sidestreamSmaller dead space:TV ratio
MAC/SedationNasal cannula samplingDetects apnoea 45 sec before SpO2 falls
Post-cardiac arrestEtCO2 trendRising EtCO2 = ROSC indicator

10. CAPNOGRAPHY IN NON-INTUBATED PATIENTS

  • Modified nasal cannula with CO2 sampling port
  • Face mask with side port sampling line
  • Useful in:
    • MAC / procedural sedation
    • PACU monitoring
    • Endoscopy sedation
    • Emergency department
  • Detects apnoea/hypoventilation 45 seconds earlier than pulse oximetry (Barash)
  • Respiratory depression 17.6× more likely to be detected with capnography vs standard monitoring alone (meta-analysis, Waugh et al.)

11. IMPORTANT COMPARISON TABLE

ParameterCapnometryCapnography
OutputNumber only (EtCO2 value)Number + Waveform
InformationQuantitative CO2Quantitative + Qualitative (pattern)
Clinical valueBasic ventilation monitoringFull ventilation + circuit + disease analysis
Preferred forSimple monitoringOT, ICU, complex cases

12. RECENT ADVANCES (2024-2026)

  • Transcutaneous CO2 (PtcCO2) monitoring: Continuous, non-invasive PaCO2 estimation - useful in neonates and NICU
  • Volumetric capnography integration into modern ICU ventilators (Draeger Evita, Hamilton) for dead space calculation and PEEP optimisation
  • Capnography for ROSC prediction strengthened in AHA 2020 CPR Guidelines - EtCO2 < 10 mmHg at 20 min = consider stopping resuscitation
  • AI-based waveform analysis of capnograms to detect early bronchospasm and circuit issues

13. CURRENT GUIDELINES

  • ASA Standards (2020): Capnography mandatory for all GA patients and strongly recommended for moderate/deep sedation
  • ESAIC: EtCO2 monitoring mandatory during neuraxial anaesthesia with sedation
  • AHA (2020 CPR): EtCO2 > 10 mmHg during CPR = adequate compressions; EtCO2 surge = ROSC
  • DAS 2015 (reaffirmed 2022): Waveform capnography mandatory for intubation confirmation in difficult airway management

📌 EXAM PEARLS

  1. Capnometry = number; Capnography = number + waveform - define both clearly
  2. Phase III plateau with upward slope (shark fin) = bronchospasm - must describe in answer
  3. Earliest sign of MH = rising EtCO2 - before temperature rises
  4. EtCO2 sudden fall to zero = disconnect, cardiac arrest, or oesophageal intubation
  5. Normal PaCO2 - EtCO2 gradient = 2-5 mmHg - increases with dead space (PE, air embolism, low CO)
  6. EtCO2 > 40 mmHg during CPR = likely ROSC - stop and check pulse

🔴 HIGH YIELD FACTS

  • EtCO2 normal = 35-45 mmHg
  • Beer-Lambert Law governs IR absorption at 4.26 μm for CO2
  • Sidestream preferred in paediatrics and MAC; Mainstream for intubated adults
  • Normal VD/VT = 0.3; Increases with PE, COPD, ARDS ventilation
  • Capnography detects apnoea ~45 sec before SpO2 falls
  • Rebreathing sign on capnogram: elevated baseline (Phase I not returning to zero)

References: Morgan & Mikhail Clinical Anesthesiology 7e, Ch. 6; Barash Clinical Anesthesia 9e, Ch. 30; Miller's Anesthesia 10e, Ch. 37; AHA CPR Guidelines 2020

Would you like to move on to the next question?

Next

Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File

THROMBOELASTOGRAPHY, VISCOELASTIC COAGULATION TESTS AND ACTIVATED CLOTTING TIME

Combined Answer: TEG (×3) | Viscoelastic Coagulation Tests | ACT | Normal TEG Diagram | Clinical Applications


1. INTRODUCTION

Limitations of Conventional Coagulation Tests (PT, aPTT, INR, platelet count)

  • Performed on platelet-poor plasma - do not assess whole blood clot dynamics
  • Static tests - do not assess clot formation speed, strength, or lysis
  • Poor correlation with actual clinical bleeding in complex situations (trauma, cardiac surgery, liver disease, obstetric haemorrhage)
  • Results take 45-60 minutes - too slow for acute haemorrhage management

Why Viscoelastic Tests?

  • Assess whole blood coagulation
  • Measure all three phases of haemostasis simultaneously:
    • Primary (platelet plug)
    • Secondary (coagulation cascade)
    • Tertiary (fibrinolysis)
  • Point-of-care (POC) results in 15-30 minutes
  • Guide targeted blood component therapy - reduce unnecessary transfusions

2. VISCOELASTIC HAEMOSTATIC ASSAYS (VHA) - OVERVIEW

FeatureTEG (Thromboelastography)ROTEM (Rotational Thromboelastometry)
DeviceHaemonetics (TEG 5000, TEG 6s)Werfen (ROTEM Delta, ROTEM Sigma)
MechanismRotating cup + stationary pin/wireFixed cup + rotating pin
MotionCup oscillates ±4.75° every 10 secPin oscillates ±4.75°
DetectionTorsion on wire by clotPin rotation resistance by clot
SampleWhole blood (citrated or native)Whole blood (citrated or native)
Volume needed~0.36 mL~0.32 mL
Reagent channelsKaolin-TEG, Platelet mapping, Functional fibrinogenINTEM, EXTEM, FIBTEM, APTEM

3. PRINCIPLE OF TEG/ROTEM

WHOLE BLOOD SAMPLE + ACTIVATOR
           |
           |--- Cup/Pin begins to move
           |--- Initially: no resistance (fluid blood)
           |--- As clot forms: resistance to motion increases
           |--- Signal transmitted → graphical trace generated
           |--- As fibrinolysis occurs: resistance decreases
  • The machine detects viscoelastic changes (changes in physical properties of blood) as it transitions from liquid → gel → lysis
  • Output = characteristic spindle-shaped waveform (TEG trace)

4. THE TEG TRACE - LABELLED DIAGRAM

                              MA
Amplitude                  ___________
(mm)             ___       /           \
                /   \     /             \       LY30
               /     \___/               \___________
              /
     R       K
|←──────→|←→|
|  Clot     Clot  |          Clot          |  Fibrinolysis
| Initiation Form |          Strength      |
|
Time ────────────────────────────────────────────────────→

5. TEG PARAMETERS - NORMAL VALUES AND CLINICAL SIGNIFICANCE

TEG ParameterROTEM EquivalentNormal ValueRepresentsProlonged/Altered in
R (Reaction time)CT (Clotting time)5-10 minTime to first fibrin strand formation (clot initiation)Factor deficiency, heparin effect, anticoagulants
K (Kinetics)CFT (Clot formation time)1-3 minTime from clot initiation to 20mm amplitude (clot formation rate)Hypofibrinogenaemia, thrombocytopenia
α angle (Alpha)α angle53-72°Rate of fibrin cross-linking; clot build-up speedFibrinogen deficiency, thrombocytopenia
MA (Maximum Amplitude)MCF (Max Clot Firmness)50-70 mmMaximum clot strength (platelet + fibrin contribution)Thrombocytopenia, platelet dysfunction, hypofibrinogenaemia
LY30LI30 (Lysis Index 30)<8%% clot lysis at 30 min after MAHyperfibrinolysis (trauma, CPB, liver disease)
CI (Coagulation Index)-3 to +3Overall coagulation statusHyper/hypocoagulable states
EPLML (Max Lysis)<15%Estimated % lysisFibrinolysis assessment
Must Remember:
  • R time = reflects intrinsic pathway + anticoagulants
  • MA = reflects platelet function + fibrinogen (most important parameter clinically)
  • LY30 = reflects fibrinolysis (key in trauma, obstetric haemorrhage)

6. ROTEM CHANNELS

ChannelActivatorWhat it Measures
INTEMContact activator (ellagic acid)Intrinsic pathway (like aPTT)
EXTEMTissue factorExtrinsic pathway (like PT)
FIBTEMCytochalasin D (blocks platelets)Fibrinogen contribution only - FIBTEM MA reflects fibrin clot without platelet contribution
APTEMAprotinin + TFFibrinolysis detection (compares with EXTEM)
HEPTEMHeparinase + contact activatorDetects heparin effect (compares with INTEM)
Exam Pearl: FIBTEM MA normal = 9-25 mm. If FIBTEM MA low → give Fibrinogen/Cryoprecipitate. If EXTEM MA - FIBTEM MA < 15mm → platelet contribution minimal → give platelets.

7. INTERPRETATION PATTERNS - VISUAL GUIDE

NORMAL TEG
|     /‾‾‾‾‾‾‾‾‾\
|    /             \
|___/               \___

FACTOR DEFICIENCY (↑R time, normal MA)
|              /‾‾‾‾\
|             /      \
|____________/        \___

THROMBOCYTOPENIA (normal R, ↓MA)
|   /‾‾‾‾\
|  /      \
|_/        \_____

FIBRINOLYSIS (normal initially, then drop in MA)
|   /‾‾‾‾\___________
|  /
|_/

HYPERCOAGULABLE (↓R, ↑α, ↑MA)
| /‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾\
|/                    \__

8. CLINICAL APPLICATIONS OF TEG/ROTEM IN ANAESTHESIA

A. Cardiac Surgery and CPB

  • Monitor heparin effect (HEPTEM vs INTEM comparison)
  • Detect residual heparin after protamine reversal
  • Guide protamine dosing
  • Detect coagulopathy post-CPB (factor deficiency vs platelet dysfunction vs fibrinolysis)

B. Trauma / Massive Haemorrhage

  • Early detection of Trauma-Induced Coagulopathy (TIC)
  • Detect hyperfibrinolysis - LY30 > 3% = fibrinolysis → give Tranexamic Acid immediately
  • Guide 1:1:1 MTP (Massive Transfusion Protocol) vs targeted therapy
  • CRASH-2 trial basis: TXA within 3 hours saves lives in trauma with coagulopathy

C. Liver Transplantation

  • Best monitor for complex coagulopathy
  • Guides each phase: anhepatic phase (heparinoid effect, fibrinolysis), reperfusion (massive fibrinolysis)
  • Reduces blood product usage by 50%

D. Obstetric Haemorrhage (PPH)

  • Rapid detection of consumptive coagulopathy and fibrinogen depletion
  • FIBTEM MA < 12 mm → Fibrinogen replacement (target > 2 g/L)
  • WOMAN trial: TXA reduces PPH mortality

E. Neurosurgery

  • Detect hypercoagulable states (DVT risk)
  • Monitor anticoagulation reversal

F. Sickle Cell / Haematological Disorders

  • Monitor hypercoagulable tendency

9. TEG-GUIDED TRANSFUSION ALGORITHM

PATIENT BLEEDING → TEG/ROTEM
           |
    ┌──────┴──────────────────┐
    |                         |
   ↑R time                  ↓MA
   (Factor deficiency)      |
    |                   ┌───┴────────┐
    ↓                   |            |
   FFP/PCC         FIBTEM ↓MA    FIBTEM normal MA
                         |            |
                   Fibrinogen/    Platelets
                   Cryoprecipitate
           |
          ↑LY30 (>3%)
           |
         Tranexamic Acid / Epsilon-ACA

10. ACTIVATED CLOTTING TIME (ACT)

Definition

  • A whole blood point-of-care clotting test that measures time from sample contact with an activator to clot formation, reflecting the intrinsic + common coagulation pathways
  • Described by Hattersley (1966) as a modification of Lee-White whole blood clotting time

Principle

  • Blood added to a tube containing a contact activator (celite/kaolin/glass beads)
  • Tube rotated or agitated; clot formation detected mechanically (magnet displacement) or optically
  • Two common systems: Hemochron (magnet-based), Hepcon HMS Plus (plumb bob)

Normal Values

ParameterValue
Normal ACT107 ± 13 seconds (approx. 70-120 sec)
Target during CPB (heparin)>480 seconds (some centres: >400 sec)
Target during ECMO180-220 seconds
Target during cardiac catheterisation250-350 seconds
Heparin reversal with protamineACT returns to baseline

Clinical Uses of ACT

SettingTarget ACTSignificance
Cardiopulmonary Bypass>480 secEnsures adequate anticoagulation before CPB
ECMO180-220 secContinuous heparin monitoring
Interventional Cardiology (PCI)250-350 secDuring coronary intervention
Vascular surgery>200 secDuring clamping
Heparin reversalReturn to baselineAdequate protamine given

Factors Affecting ACT (Causes of Falsely Prolonged ACT)

FactorEffect
HypothermiaProlongs ACT (enzymatic reactions slow)
HaemodilutionProlongs ACT
ThrombocytopeniaProlongs ACT
AprotininProlongs ACT (use Kaolin-ACT instead of Celite-ACT with aprotinin)
Factor deficienciesProlongs ACT
>600 secExceeds linear range of assay - not reliable

Limitations of ACT

  • Insensitive at low heparin concentrations
  • Poor reproducibility in some systems
  • Cannot assess platelet function or fibrinolysis
  • Not a substitute for full haemostasis assessment
  • Aprotinin causes falsely prolonged Celite-ACT but not Kaolin-ACT

11. COMPARISON: CONVENTIONAL TESTS vs VISCOELASTIC TESTS vs ACT

ParameterPT/aPTT/INRTEG/ROTEMACT
SamplePlatelet-poor plasmaWhole bloodWhole blood
What it measuresPlasma coagulation onlyAll phases of haemostasisIntrinsic pathway (heparin)
Time45-60 min15-30 min5-15 min
Fibrinolysis detectedNoYesNo
Platelet functionNoYesPartial
Heparin monitoringPartial (aPTT)Yes (HEPTEM)Primary use
POC capableNoYesYes
Guides transfusionLimitedBestNo

12. RECENT ADVANCES (2024-2026)

  • TEG 6s (Haemonetics): Cartridge-based, no pipetting, 4 simultaneous channels, minimal operator skill - now entering many Indian cardiac centres
  • ROTEM Sigma: Fully automated ROTEM - reduces operator variability
  • Viscoelastic-guided MTP: Multiple RCTs (ITACTIC 2020, CRYOSTAT-2 2023) show TEG/ROTEM-guided transfusion reduces blood product use and is non-inferior to empirical 1:1:1 MTP
  • SSC 2021 / ESICM 2023: Recommend viscoelastic monitoring for coagulopathy in sepsis and major haemorrhage
  • FIBTEM-guided fibrinogen supplementation now standard of care in obstetric haemorrhage management (OAA/RCOG 2023)

13. CURRENT GUIDELINES

  • European Trauma Guidelines (2023): VHA recommended for guiding haemostatic resuscitation in major trauma
  • ESAIC/ESA (2023): TEG/ROTEM recommended for all major surgeries with expected significant blood loss
  • COBS/OAA (2023): FIBTEM-guided fibrinogen replacement in PPH
  • STS/AHA Cardiac Surgery (2021): TEG/ROTEM for coagulation management during and after CPB

📌 EXAM PEARLS

  1. R time (TEG) = CT (ROTEM) = clot initiation = factor deficiency → give FFP/PCC
  2. MA (TEG) = MCF (ROTEM) = clot strength = platelet + fibrin → if low, check FIBTEM
  3. LY30 > 3% = pathological fibrinolysis → give Tranexamic Acid immediately
  4. FIBTEM MA = fibrinogen contribution only (platelets blocked) → if low, give cryoprecipitate/fibrinogen concentrate
  5. Normal ACT = 107 ± 13 sec; CPB target = >480 sec
  6. Hypothermia and haemodilution both prolong ACT - correct temperature before interpreting

🔴 HIGH YIELD FACTS

  • TEG rotating cup vs ROTEM fixed cup - remember this distinction (favourite viva question)
  • ACT measures intrinsic + common pathway - used for heparin monitoring in cardiac surgery
  • Aprotinin + Celite ACT = falsely prolonged; use Kaolin ACT with aprotinin
  • TEG/ROTEM identifies the type of coagulopathy → targeted therapy saves blood products
  • FIBTEM channel = fibrinogen quantification in whole blood without platelet interference
  • Normal LY30 < 8% in TEG; pathological fibrinolysis = >3% (Trauma threshold)

References: Miller's Anesthesia 10e, Ch. 45 & Ch. 57; Quick Compendium of Clinical Pathology 5e; Tintinalli's Emergency Medicine 9e; European Trauma Guidelines 2023; ESAIC 2023

Would you like to move on to the next question?

Next

Finding Sources
Finding Sources
Reading File
Reading File

TRANSOESOPHAGEAL ECHOCARDIOGRAPHY (TOE/TEE) IN ANAESTHESIA PRACTICE

Combined Answer: Use of TOE in Anaesthesia (×2)


1. DEFINITION

  • TOE (Transoesophageal Echocardiography) / TEE (Transesophageal Echocardiography): A semi-invasive cardiac imaging modality in which an ultrasound transducer mounted on a modified endoscope is introduced into the oesophagus and stomach to obtain high-resolution real-time images of cardiac structures, function, and haemodynamics
  • Provides superior image quality compared to transthoracic echocardiography (TTE) due to proximity of the oesophagus to the heart (posterior cardiac structures especially) and absence of lung/rib interference

2. RELEVANT ANATOMY

Anatomical Basis for TOE Windows

OESOPHAGUS POSITION RELATIVE TO HEART:
Oesophagus → lies directly POSTERIOR to left atrium
                     ↓
         Excellent views of:
         • Left atrium (LA)
         • Mitral valve
         • Left atrial appendage (LAA)
         • Pulmonary veins
         • Descending aorta
         • Aortic arch (from gastric window)
  • Distance from incisors:
    • Upper oesophageal (UE): 20-25 cm - aortic arch views
    • Mid-oesophageal (ME): 30-35 cm - most common views (4-chamber, AV, bicaval)
    • Trans-gastric (TG): 40-45 cm - LV short axis, RV inflow-outflow

3. PROBE AND EQUIPMENT

ComponentDetails
Transducer frequency3.5-7 MHz (phased array)
Probe tip movement4 degrees of freedom: advance/withdraw, anteflex/retroflex, rotate left/right, turn
Multiplane imagingOmniplane angle: 0° to 180° (rotates electronically)
Probe size (adult)9-10 mm diameter tip
Paediatric probe5-7 mm (for children >2 kg)
3D TOEMatrix array probe - enables real-time 3D and 4D imaging

4. THE 20 STANDARD TOE VIEWS (ASE/SCA Guidelines)

Key Views for Anaesthesia Practice

ViewProbe PositionOmniplane AngleWhat It Shows
ME 4-ChamberMid-oesophagealLV/RV size & function, MV, TV
ME 2-ChamberMid-oesophageal90°LV anterior & inferior walls, MV
ME Long Axis (LAX)Mid-oesophageal120°LVOT, Aortic valve, MV
ME AV SAXMid-oesophageal30-60°Aortic valve (short axis - "Mercedes Benz")
ME BicavalMid-oesophageal90-110°SVC, IVC, RA, interatrial septum
TG Mid SAXTrans-gastricLV short axis - wall motion monitoring (GOLD STANDARD for ischaemia)
TG 2-ChamberTrans-gastric80-100°LV long axis
TG RV InflowTrans-gastric100-120°RV, TV, RVOT
UE Aortic Arch SAXUpper oesophagealAortic arch, pulmonary artery
DESC Aorta SAX/LAXDescending0°/90°Descending thoracic aorta
Exam Pearl: TG Mid SAX (Transgastric Midpapillary Short Axis) at 0° is the most important single view - shows all 3 coronary territories simultaneously for wall motion analysis.

5. INDICATIONS FOR INTRAOPERATIVE TOE

Class I Indications (Strong Evidence - Recommended)

(ASE/SCA 2010, reaffirmed 2024)
  • All open heart surgeries (valve repair/replacement, CABG, aortic surgery)
  • Cardiac transplantation
  • Congenital heart disease repair
  • Thoracic aortic disease (aortic dissection, aneurysm)
  • Haemodynamic instability intraoperatively when cause is unclear
  • Lung transplantation

Class II Indications (Good Evidence - May Be Used)

  • High-risk non-cardiac surgery (major vascular, orthotopic liver transplant)
  • Suspected cardiac embolism source
  • Pericardial effusion / cardiac tamponade
  • Intracardiac thrombus detection (esp. LAA)
  • Assessment of volume status in high-risk surgical patients
  • Air embolism detection (sitting craniotomy, hepatic surgery)
  • Thoracic surgery - lung resection (tumour invasion, RV function)
  • Repair of structural heart disease (TAVI, MitraClip, ASD closure - on CPB or percutaneous)

Class III Indications (Limited Evidence)

  • Routine monitoring in non-cardiac low-risk surgery
  • Haemodynamically stable patients on CPB for minor procedures

6. WHAT TOE MEASURES/ASSESSES

A. Ventricular Function

AssessmentTOE FindingClinical Use
LV systolic functionEF estimation (visual / biplane Simpson)Normal EF > 55%
Wall motion abnormalities (RWMA)New regional hypokinesia/akinesiaMyocardial ischaemia
LV diastolic functionE/A ratio, E/e' ratio, pulmonary venous flowDiastolic dysfunction
RV functionRV size, TAPSE, FACRV failure after pneumonectomy, PE
Volume status (preload)LV end-diastolic area (LVEDA) on TG SAXHypovolaemia: small, hyperkinetic LV

B. Valvular Assessment

  • Mitral valve: Area, regurgitation, repair assessment (post-repair SAM)
  • Aortic valve: Stenosis (PHT, continuity equation), regurgitation (vena contracta)
  • Tricuspid valve: Regurgitation, PA pressure estimation (TR jet velocity)
  • Pulmonary valve: Regurgitation, RVOT obstruction

C. Aortic Pathology

  • Aortic dissection: Intimal flap, true/false lumen, involvement of coronary ostia
  • Ascending aortic aneurysm: Size, morphology
  • Atheroma: Grading (Grades I-V) - important for cannulation site in CABG

D. Structural Defects

  • Patent Foramen Ovale (PFO): Bubble contrast study
  • ASD/VSD: Size, flow direction, Qp:Qs ratio
  • Intracardiac thrombus (esp. LAA)
  • Pericardial effusion: Size, tamponade physiology (RA/RV collapse)

E. Haemodynamic Parameters from TOE

ParameterMeasurement MethodNormal Value
Cardiac OutputLVOT VTI × LVOT area × HR4-8 L/min
Stroke VolumeLVOT VTI × LVOT area60-100 mL
PA systolic pressure4V² (TR jet) + CVP15-30 mmHg
Mean PA pressure4V² (PR jet) + CVP10-20 mmHg
PCWP (estimated)E/e' ratioE/e' > 14 = elevated PCWP
LV filling pressureE/e' lateral>10 = elevated

7. CLINICAL APPLICATIONS IN ANAESTHESIA (SYSTEM-WISE)

A. Cardiac Surgery (CPB)

  • Pre-CPB: Confirm diagnosis, assess valvular anatomy, LV/RV function baseline, check for PFO, grade aortic atheroma
  • During CPB: Detect air in cardiac chambers before weaning
  • Post-CPB: Assess adequacy of repair/replacement, detect residual lesions, assess RV/LV function, detect paravalvular leaks
  • De-airing: Confirm all chambers free of air before removing aortic cross-clamp

B. Non-Cardiac Surgery

  • Haemodynamic instability: Rapid diagnosis - hypovolaemia vs cardiogenic vs obstructive shock
  • Suspected PE: RV dilatation + McConnell sign + D-sign on LV
  • Pericardial tamponade: RA/RV diastolic collapse, IVC plethora, swinging heart
  • Aortic dissection: Intimal flap in descending aorta

C. Thoracic Surgery

  • RV function monitoring during pneumonectomy
  • Tumour invasion of heart/great vessels
  • Detection of PFO (right-to-left shunt during OLV/PEEP)
  • Air embolism detection

D. Liver Transplantation

  • Monitor volume status in all 3 phases
  • Detect portopulmonary hypertension
  • Post-reperfusion myocardial dysfunction

E. Obstetric Anaesthesia

  • Cardiac arrest in pregnancy - diagnose cause
  • Peripartum cardiomyopathy assessment

8. CONTRAINDICATIONS

Absolute Contraindications

  • Oesophageal obstruction / stricture
  • Oesophageal tumour / perforation
  • Active oesophageal varices (relative - Grade III/IV)
  • Recent oesophageal surgery

Relative Contraindications

  • Oesophageal varices (Grade I/II - use with caution)
  • Cervical spine instability
  • Coagulopathy (INR > 2.5 or platelets < 50,000)
  • Recent upper GI surgery
  • Uncooperative awake patient (unless sedated)
  • Oropharyngeal pathology

9. COMPLICATIONS

ComplicationIncidence
Oesophageal perforation0.01-0.03% (most serious)
Dental/oropharyngeal injury0.1%
Oesophageal tear/haematomaRare
Laryngospasm / bronchospasmRare
Arrhythmias during insertionUncommon
Bleeding from varicesRare
Mortality<0.01%
Must Remember: TOE is semi-invasive - complications are rare but the oesophageal perforation is potentially fatal.

10. TOE vs TTE - COMPARISON TABLE

FeatureTOETTE
Image qualitySuperiorLimited by body habitus, lung
InvasivenessSemi-invasiveNon-invasive
Posterior structuresExcellent (LA, MV, LAA, aorta)Limited
Anterior structuresLimitedBetter
Intraoperative useStandardLimited
Patient cooperationNot required (GA/sedation)Required
ContraindicationsOesophageal pathologyMinimal
Real-time CO monitoringYes (LVOT VTI)Yes (less reliable in OT)
3D capabilityYes (matrix probe)Yes

11. FOCUSED CARDIAC ULTRASOUND (FOCUS) vs COMPREHENSIVE TOE

FeatureFOCUS / Rescue TOEComprehensive TOE
Time2-5 minutes20-40 minutes
ScopeLimited - answers specific questionComplete 20-view examination
TrainingBasic (Level I)Advanced (Level II/III)
UseEmergency, haemodynamic instabilityCardiac surgery, planned assessment
Questions answeredWhy is this patient unstable?Full structural + functional assessment

12. TRAINING AND COMPETENCY

  • Level I (Basic): Understanding of TOE, limited views, interpretation with supervision
  • Level II (Advanced): Comprehensive perioperative TOE - 300 supervised examinations
  • Level III (Expert): Teaching and research
Certifications:
  • NBE (National Board of Echocardiography) - USA: PTEeXAM (Basic) and DBNPE (Advanced)
  • ASE/SCA Guidelines (2020): Training standards for perioperative echocardiography

13. RECENT ADVANCES (2024-2026)

  • 3D/4D TOE: Real-time 3D imaging for structural interventions (TAVI, MitraClip, Watchman LAA occlusion) - now standard
  • AI-assisted TOE interpretation: Automated EF calculation, wall motion analysis, valve quantification - FDA-approved tools (EchoGo, Caption Health)
  • Point-of-care TOE (handheld TOE probes - CX50, Vscan Ultra) now available
  • TOE for ECMO cannulation guidance - indispensable for VA-ECMO and VV-ECMO
  • ESAIC 2023: Recommends TOE competency as core skill for cardiac anaesthesiologists
  • TAVI guidance: TOE has become indispensable for transcatheter valve interventions - guides device sizing, deployment, leak assessment

14. CURRENT GUIDELINES

  • ASE/SCA (2010, reaffirmed 2022): Indications, training standards, 20 standard views
  • ESA/ESAIC (2021): Perioperative TOE recommended for all cardiac surgery and high-risk non-cardiac surgery
  • ACC/AHA (2021 Valve Guidelines): TOE mandatory for intraoperative valve assessment
  • SCCM (2023): POCUS/TOE recommended for haemodynamic assessment in ICU shock states

📌 EXAM PEARLS

  1. ME 4-Chamber view at 0° = first and most informative view in any emergency
  2. TG Mid SAX at 0° = gold standard for wall motion analysis (all 3 coronary territories: LAD, LCx, RCA)
  3. Hypovolaemic LV on TOE = small, hyperkinetic ventricle with "kissing papillaries" (walls touch in systole)
  4. Cardiac tamponade on TOE = RA collapse in systole + RV collapse in diastole + IVC plethora (non-collapsing)
  5. Post-MVR on TOE = always look for SAM (systolic anterior motion of MV) after repair
  6. TOE is contraindicated in oesophageal stricture, perforation, active varices - always ask history before inserting probe

🔴 HIGH YIELD FACTS

  • TOE probe frequency: 3.5-7 MHz - lower frequency = better penetration (vice versa for resolution)
  • Normal LV EF = >55% | Mildly reduced = 45-54% | Moderately reduced = 30-44% | Severely reduced = <30%
  • PA systolic pressure estimation: 4 × (TR jet velocity)² + CVP (simplified Bernoulli)
  • E/e' > 14 = elevated LV filling pressures (diastolic dysfunction)
  • LAA thrombus is best seen on TOE (ME bicaval or ME 4-chamber with probe at 0-90°)
  • 3D TOE revolutionised structural heart disease interventions - TAVI, MitraClip now TOE-guided routinely

References: Miller's Anesthesia 10e, Ch. 49; Barash Clinical Anesthesia 9e, Ch. 27; Textbook of Clinical Echocardiography 7e; ASE/SCA Guidelines 2022; ESAIC 2023

Would you like to move on to the next question?

Next

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File

NEUROMUSCULAR MONITORING

Combined Answer: Neuromuscular Monitoring (×3) | Train of Four + Post-Tetanic Count | Double Burst Stimulation (×2) | Various Modes of Nerve Stimulation + Interpretation | Utility of Peripheral Nerve Stimulator


1. DEFINITION AND IMPORTANCE

  • Neuromuscular monitoring: Objective assessment of the degree of neuromuscular blockade (NMB) using a peripheral nerve stimulator (PNS) applied over a motor nerve, and measuring the evoked muscle response
  • Why essential:
    • NMBDs (neuromuscular blocking drugs) have narrow therapeutic window
    • Residual NMB (TOF ratio < 0.9) occurs in 30-60% of patients arriving in PACU without objective monitoring
    • Residual NMB causes: pharyngeal dysfunction, aspiration, hypoxaemia, upper airway obstruction, impaired hypoxic ventilatory response
    • ASA 2023 / ESAIC 2023: Objective quantitative NMB monitoring is recommended as standard of care

2. RELEVANT PHYSIOLOGY

Neuromuscular Junction (NMJ) - Brief

Motor nerve axon
       |
  Presynaptic terminal
       |--- ACh synthesised & stored in vesicles
       |--- α3β2 presynaptic nicotinic receptors (autoreceptors)
              → Mobilises ACh release for sustained stimulation
  Synaptic cleft
       |--- AChE degrades ACh
  Postsynaptic membrane
       |--- α1β1δε nicotinic receptors (muscle type)
       |--- 2 α-subunits must be occupied by ACh for channel opening
  • Non-depolarising NMBDs block postsynaptic α1 receptors (competitive antagonism) AND presynaptic α3β2 receptors (explaining fade on TOF/tetanus)
  • Depolarising NMBDs (Succinylcholine): Bind α1 → persistent depolarisation → fasciculations → flaccid paralysis

3. MONITORING SITES AND ELECTRODE PLACEMENT

Preferred SiteNerveMuscleAdvantage
Ulnar nerve at wrist (most common)Ulnar nerveAdductor pollicisGold standard; reflects diaphragm & airway muscle sensitivity
Facial nerve (tragus)Facial nerveOrbicularis oculiAccessible in head/neck surgery
Tibial nerve (ankle)Posterior tibialFlexor hallucis brevisWhen hand inaccessible
Common peronealCommon peronealExtensor hallucisAlternative lower limb
Exam Pearl: The adductor pollicis (thumb) is most sensitive to NMBDs. Recovery here lags behind the diaphragm and larynx. So TOF ratio ≥0.9 at thumb does NOT mean larynx/diaphragm is fully recovered - they recover EARLIER. This is why extubation should wait for TOF ≥ 0.9 at thumb.

4. STIMULATION PARAMETERS (PNS Settings)

ParameterStandard Value
WaveformMonophasic square wave
Pulse duration0.1-0.3 msec (200-300 μsec)
Current (supramaximal)20-60 mA (always use supramaximal to ensure all fibres activated)
PolarityNegative electrode DISTAL (over nerve)
TemperatureBest at 32-34°C skin temp (hypothermia prolongs block)

5. MODES OF NERVE STIMULATION

A. Single Twitch Stimulation

  • Frequency: 0.1 Hz (1 stimulus every 10 sec) or 1 Hz (1/sec)
  • What it measures: Height of single muscle twitch compared to control (pre-NMB baseline)
  • Requires baseline recording before NMB administration
  • Interpretation:
% Twitch Height vs BaselineBlock Depth
100%No block
75%Light block
25%Moderate block - adequate for most surgery
10%Deep block
0%Complete block (total twitch suppression)
  • Limitation: Cannot assess residual block (cannot compare T1 to baseline at end of surgery without initial recording)
  • Use: Monitoring onset and depth of block; not for recovery assessment

B. Train-of-Four (TOF) Stimulation ⭐ (Most Important)

  • Introduced by Ali et al. (1970)
  • Frequency: 2 Hz - four stimuli given over 2 seconds
  • Repeat interval: Every 15 seconds minimum (to avoid potentiation)
  • No baseline recording needed - uses ratio of T4/T1

TOF Response Pattern

SEQUENCE: T1 → T2 → T3 → T4 (at 2 Hz over 2 sec)

ONSET OF BLOCK (Deepening):
T4 disappears first → T3 → T2 → T1 (last to disappear)

RECOVERY (Regression):
T1 returns first → T2 → T3 → T4 (last to return)

TOF Count vs Depth of Block

TOF CountBlock DepthClinical Significance
4 twitchesMild/moderate blockTOF ratio < 0.9 = residual block
3 twitchesModerate block~75% receptors blocked
2 twitchesDeep block~80% receptors blocked
1 twitchVery deep block~90% receptors blocked
0 twitchesIntense block>95% receptors blocked

TOF Ratio

TOF RatioInterpretationAction
≥0.9Adequate recoverySafe to extubate
0.7-0.9Residual blockClinical signs unreliable; give sugammadex/neostigmine
0.4-0.7Significant blockReversal needed
<0.4Deep blockDo NOT reverse with neostigmine; use sugammadex
<0.1Intense blockSugammadex 16 mg/kg
Must Remember: TOF ratio ≥ 0.9 = current definition of adequate reversal (Kopman 1995, reaffirmed ESAIC 2023). NOT 0.7 - this is an outdated threshold.

C. Tetanic Stimulation

  • Frequency: 50 Hz (standard) or 100 Hz (high sensitivity)
  • Duration: 5 seconds
  • Principle: High-frequency stimulation depletes presynaptic ACh at a rate faster than mobilisation → if partial NMB exists → fade of tetanic response
  • Post-tetanic facilitation (PTF): After tetanus, subsequent single twitches are enhanced for 1-2 min due to increased ACh mobilisation
Tetanic ResponseBlock Type
No fadeNo block (or full depolarising block)
Sustained fadeNon-depolarising block
Initial fade, then sustainedPhase II block (prolonged SCh)
  • 50 Hz fade correlates with TOF ratio ≈ 0.4
  • 100 Hz fade correlates with TOF ratio ≈ 0.85 (more sensitive)
  • Limitation: Painful in awake patients; must wait 2-3 min before repeating

D. Post-Tetanic Count (PTC) ⭐

  • Used when TOF count = 0 (intense/deep NMB)
  • Technique:
    1. Apply 50 Hz tetanus for 5 seconds
    2. Wait 3 seconds
    3. Apply 1 Hz single twitches × 15
    4. Count the number of twitches that appear (PTC)
  • Interpretation:
PTCApproximate Time to TOF Count 1Clinical Meaning
0>20-25 minProfound block; no reversal possible
1-2~10-15 minVery deep block
3-5~5-10 minDeep block; sugammadex 4 mg/kg
≥6<5 minModerate deep block; recovery soon
Exam Pearl: PTC is the only mode useful in profound/intense block where TOF = 0. Essential during RSI for difficult airway, or when intense block is required for surgical access (e.g., laparoscopy, spinal surgery).

E. Double Burst Stimulation (DBS) ⭐

  • Introduced by Viby-Mogensen (1989)
  • Designed to overcome the limitation of subjective TOF fade detection
  • Technique: Two short bursts of 50 Hz tetanic stimulation
    • DBS 3,3: Two bursts of 3 stimuli each at 50 Hz, separated by 750 msec
    • Each burst: 3 impulses at 50 Hz (60 msec duration)
DBS 3,3 Pattern:
Burst 1: |||  (750 msec gap)  Burst 2: |||
         3 stimuli at 50 Hz           3 stimuli at 50 Hz
         →  Response 1                →  Response 2
  • What it detects: If Response 2 < Response 1 = fade present = residual NMB
  • Advantage over TOF fade: Human tactile and visual detection of fade is more sensitive with DBS than with TOF
    • DBS detects fade corresponding to TOF ratio down to 0.6
    • TOF subjective fade detection: only down to 0.3-0.4

DBS Interpretation

DBS ResultTOF Ratio (approx.)Significance
No fade (equal responses)≥0.6May still have residual block - need objective measurement
Fade present<0.6Definite residual block
High Yield: DBS is better than TOF for subjective/manual residual block detection. But neither replaces objective quantitative monitoring (acceleromyography, electromyography).

6. SUMMARY TABLE: ALL STIMULATION MODES

ModeFrequencyPatternPrimary UseTOF Ratio Sensitivity
Single Twitch0.1-1 HzSingle pulseOnset/depthNot useful
Train-of-Four (TOF)2 Hz4 pulses/2 secStandard - depth + recoveryDown to 0.3-0.4 (subjective)
Tetanus50/100 Hz5 sec sustainedFade detection, post-tetanic50Hz→0.4; 100Hz→0.85
Post-Tetanic Count (PTC)50Hz + 1 HzTetanus then twitchesProfound block monitoringNot applicable (TOF = 0)
DBS 3,350 Hz (×2)2 bursts of 3Residual block (better than TOF)Down to 0.6

7. OBJECTIVE vs SUBJECTIVE MONITORING

Subjective Methods (using PNS alone)

  • Tactile or visual assessment of thumb movement
  • Cannot reliably detect TOF ratio between 0.4 and 0.9 (the "blind zone")
  • 10-20% of clinicians cannot subjectively detect fade when TOF ratio is 0.7-0.9

Objective Methods (Quantitative NMB Monitoring)

MethodPrincipleGold Standard?
Mechanomyography (MMG)Force transducer measures isometric contractionYes - research standard
Electromyography (EMG)Measures compound muscle action potentialHigh accuracy
Acceleromyography (AMG)Piezoelectric crystal - measures thumb accelerationMost common clinical
Kinemyography (KMG)Measures bend/flex of thumb (Datex-Ohmeda M-NMT)Clinical use
PhonomyographyAcoustic myographyResearch
AMG TOF ratio must be normalised to baseline - uncorrected AMG may read 1.0-1.2 at full recovery, so TOF ratio ≥0.9 must be confirmed against a pre-NMB baseline recording.

8. DEPTH OF NMB CLASSIFICATION

DepthTOF CountPTCClinical Use
Intense/Profound00RSI, tracheal surgery, absolute immobility
Deep01-5Laparoscopy, spinal surgery, optimal conditions
Moderate1-3>5Standard surgical conditions
Mild/Shallow4TOF ratio <0.9 - reversal needed
Full Recovery4TOF ratio ≥0.9 - safe to extubate

9. CLINICAL APPLICATIONS IN ANAESTHESIA

Intraoperative

  • Monitor NMB depth throughout surgery
  • Guide redosing of NMBD
  • Reversal timing:
    • Neostigmine: TOF count ≥ 4 twitches (TOF ratio ≥ 0.4)
    • Sugammadex: Can reverse at any depth
      • Shallow: 2 mg/kg (TOF ratio ≥ 0.2)
      • Deep (TOF 1-2): 4 mg/kg
      • Profound/Intense (TOF 0): 16 mg/kg

Post-Extubation

  • Before extubation: Objective TOF ratio ≥ 0.9 mandatory
  • Clinical signs unreliable for residual NMB detection:
    • 5-second head lift (TOF ratio ≈ 0.6 - not sufficient!)
    • Sustained 5-sec hand grip
    • Tongue protrusion
    • These correspond to TOF ≈ 0.6 - NOT 0.9
Must Remember: Classic clinical tests (head lift for 5 sec, hand grip, leg lift) only require TOF ratio of approximately 0.6 - they CANNOT confirm adequate reversal to TOF ≥ 0.9.

10. RESIDUAL NMB - KEY FACTS

FactValue
Definition of residual NMBTOF ratio <0.9
Incidence without monitoring30-60% in PACU
Pharyngeal dysfunction occurs atTOF ratio <0.9
Hypoxic ventilatory response impaired atTOF ratio <0.7
Upper airway obstruction thresholdTOF ratio <0.8
5-sec head lift achievable atTOF ratio ≈ 0.6
Sustained tetanus (100 Hz) detectable atTOF ratio ≈ 0.85

11. RECENT ADVANCES (2024-2026)

  • ESAIC 2023 Consensus Statement: Quantitative NMB monitoring is now a standard of care recommendation - not optional
  • TOFscan (Idmed): Compact, acceleromyographic device with automatic normalization - increasingly adopted
  • Stimpod NMS450X: EMG-based NMB monitor - superior accuracy over AMG
  • TetraGraph: Surface EMG device - validated against MMG gold standard
  • Closed-loop NMB delivery: Automated NMB dosing system using real-time TOF feedback - Phase III trials ongoing (2024-2025)
  • AI integration: Algorithms predicting residual NMB and optimal reversal timing

12. CURRENT GUIDELINES

  • ESAIC Consensus (2023): Quantitative NMB monitoring recommended; TOF ratio ≥0.9 for extubation; sugammadex preferred reversal agent
  • ASA (2023 Practice Advisory Update): Objective NMB monitoring recommended for all patients receiving NMBDs
  • POQI (Perioperative Quality Initiative 2019/2023): Sugammadex + quantitative monitoring bundle reduces residual NMB and respiratory complications
  • DAS 2015 guidelines: NMB monitoring integral to difficult airway management - know block depth before reversal in failed intubation drill

📌 EXAM PEARLS

  1. TOF = 4 twitches at 2 Hz over 2 sec - repeat every 15 sec minimum
  2. TOF ratio ≥ 0.9 = adequate recovery - NOT 0.7 (old threshold)
  3. PTC = only useful when TOF count = 0 (intense block) - do not confuse with TOF
  4. DBS 3,3 = better subjective residual block detection than TOF (detects down to ratio 0.6)
  5. 5-second head lift = TOF ratio ≈ 0.6, NOT 0.9 - unreliable for adequate reversal
  6. Adductor pollicis (thumb) recovers LAST - most sensitive and conservative monitoring site

🔴 HIGH YIELD FACTS

  • Fade on TOF/tetanus = non-depolarising block (prejunctional α3β2 receptor blockade)
  • No fade (sustained block) = depolarising block (Phase I SCh block)
  • TOF T4 disappears first, T1 last with deepening non-depolarising block
  • PTC 1-2 = expect TOF response in ~10-15 min (time to allow for surgical closure)
  • Sugammadex 16 mg/kg reverses even intense block (TOF count 0, PTC 0) in < 3 min
  • Neostigmine is unreliable when TOF count < 4 (blocks already deep - ceiling effect)

References: Barash Clinical Anesthesia 9e, Ch. 21; Miller's Anesthesia 10e, Ch. 29; Morgan & Mikhail Clinical Anesthesiology 7e; ESAIC Consensus on NMB Monitoring 2023; Viby-Mogensen J et al. 1989 (DBS)

Would you like to move on to the next question?

Next

Finding Sources
Finding Sources
Reading File
Finding Sources

BISPECTRAL INDEX (BIS) MONITORING

Combined Answer: BIS Guidelines (×2) | Depth of Anaesthesia Monitoring | Awareness Prevention


1. DEFINITION

  • BIS (Bispectral Index): A processed EEG (electroencephalography) parameter derived from a proprietary algorithm that analyses the EEG signal from the frontal cortex and converts it into a single dimensionless number (0-100) representing the depth of anaesthesia / sedation
  • 0 = electrically silent brain (isoelectric EEG)
  • 100 = fully awake, alert
  • Originally developed by Aspect Medical Systems (now Medtronic)

2. PHYSIOLOGICAL BASIS - EEG AND ANAESTHESIA

EEG Frequency Bands

BandFrequencyAwake State
Beta13-30 HzAlert, conscious, active
Alpha8-13 HzRelaxed, eyes closed
Theta4-8 HzDrowsy, light sedation
Delta0.5-4 HzDeep sleep, deep anaesthesia
Burst suppressionIrregularVery deep anaesthesia
Isoelectric0 HzAnaesthetic overdose / brain death

Effect of Anaesthetics on EEG

AWAKE → Low amplitude, high frequency (Beta)
         ↓ (light sedation)
       Increasing amplitude, decreasing frequency (Alpha → Theta)
         ↓ (surgical anaesthesia)
       High amplitude, slow waves (Delta)
         ↓ (deep anaesthesia)
       Burst suppression pattern
         ↓ (overdose)
       Isoelectric (flat line)

3. HOW BIS IS DERIVED

The BIS algorithm analyses four EEG sub-parameters:
Sub-parameterWhat it measures
BetaRatioLog ratio of power in 30-47 Hz / 11-20 Hz. Reflects sedation (decreases with depth)
SynchFastSlowBispectral parameter - phase coupling between slow and fast frequencies (increases with depth)
Burst Suppression Ratio (BSR)% of time EEG is isoelectric in last 63 sec (increases with very deep anaesthesia)
QUAZI (near suppression)Detects near-suppression periods that do not fully meet BSR criteria
These are combined in a weighted multivariate algorithm → BIS value
Exam Pearl: BIS is not a single EEG parameter - it is a composite derived index from multiple EEG analyses. This is why it can differ from raw EEG interpretation.

4. BIS VALUE SCALE AND CLINICAL INTERPRETATION

BIS ValueStateClinical Meaning
100Fully awakeEyes open, responding
80-100Sedated/drowsyConscious sedation range
70-80Light anaesthesiaMemory may be intact; risk of awareness
60-70Moderate anaesthesiaLow recall, adequate for most procedures
40-60General anaesthesiaTARGET RANGE for GA - no awareness, no recall
<40Deep anaesthesiaBurst suppression beginning
<30Burst suppressionDeep suppression - associated with worse outcomes
0Isoelectric / flat EEGBrain death / extreme overdose
Must Remember: BIS 40-60 = target for general anaesthesia. BIS <40 = burst suppression = risk of postoperative cognitive dysfunction (POCD) and delirium in elderly.

5. BIS COMPONENTS DISPLAYED ON MONITOR

Display ParameterMeaning
BIS value0-100 composite index
SQI (Signal Quality Index)0-100% - reliability of BIS value (>50% acceptable; >80% ideal)
EMG barElectromyographic interference (facial muscle activity) - if high, BIS is unreliable
SR (Suppression Ratio)% EEG suppression - should be 0% during surgical anaesthesia
EEG waveformRaw frontal EEG display
Spectral edge frequency (SEF)Frequency below which 95% of EEG power lies

6. BIS SENSOR PLACEMENT

  • Site: Forehead - left or right side (frontal lobe)
  • Sensor: 4-electrode adhesive strip (BIS Quatro sensor)
  • Electrode positions:
    • Electrode 1: Above eyebrow (Fp1/Fp2)
    • Electrode 2: Temple region (F3/F4)
    • Electrode 3: Next to outer canthus of eye
    • Electrode 4: On forehead between eyes (reference)
  • Impedance: Must be < 5 kΩ for reliable reading
  • Must clean skin with alcohol and allow to dry before applying

7. CLINICAL USES OF BIS IN ANAESTHESIA

A. Prevention of Intraoperative Awareness

Landmark Trials:
TrialYearFinding
B-Aware (Myles et al.)2004, LancetBIS-guided GA reduced awareness by 82% vs standard practice
B-Unaware (Avidan et al.)2008, NEJMBIS not superior to end-tidal agent monitoring for awareness prevention
BAG-RECALL (Avidan et al.)2011, NEJMEnd-tidal agent protocol = BIS protocol for awareness prevention
Key Conclusion: BIS is not superior to end-tidal anaesthetic agent concentration (ETAC) monitoring for awareness prevention in non-high-risk patients. However, in TIVA (no volatile agent), BIS is the only objective depth monitor.

B. TIVA (Total Intravenous Anaesthesia)

  • Most important indication for BIS - no ETAC available
  • Propofol-remifentanil TIVA: BIS target 40-60
  • Guides propofol infusion rate

C. High-Risk Patients for Awareness

  • Cardiac surgery (haemodynamically compromised, low MAC required)
  • Obstetric GA (low anaesthetic concentration used pre-delivery)
  • Major trauma surgery
  • Patients with prior awareness episodes
  • Patients with chronic alcohol/drug use (higher MAC requirement)

D. Titration of Anaesthetic Dose

  • Avoids both over-dosing (BIS <40) and under-dosing (BIS >60)
  • Reduces anaesthetic consumption by 10-30% with BIS guidance
  • Reduces recovery time and PACU stay

E. Sedation Monitoring in ICU

  • BIS-guided sedation protocol
  • Target BIS 60-70 for light sedation (RASS -1 to -2)
  • Target BIS 40-60 for deep sedation (RASS -3 to -4)
  • Reduces excessive sedation, delirium, ventilator days

F. Detection of Burst Suppression

  • BSR > 0% in surgical anaesthesia = excessive depth
  • Associated with postoperative delirium and POCD in elderly (CODA trial, 2019)
  • Avoid BIS < 40 in patients > 65 years

8. OTHER PROCESSED EEG MONITORS (DEPTH OF ANAESTHESIA)

MonitorDeviceParameterTarget (GA)
BISMedtronicBIS 0-10040-60
EntropyGE/Datex-OhmedaState Entropy (SE) + Response Entropy (RE)SE 40-60
NarcotrendMT MonitorTechnikA-F (EEG stages)Stage D-E
SedLine (PSi)MasimoPatient State Index (PSI)25-50
CSM (Cerebral State Monitor)DanmeterCSI 0-10040-60
aepEXMedical Device ManagementAuditory Evoked Potential Index15-25
Exam Pearl: Response Entropy (RE) > State Entropy (SE) = patient is mounting a response to noxious stimulus (frontal EMG activity) - suggests inadequate analgesia, not just light anaesthesia.

9. FACTORS AFFECTING BIS (CAUSES OF INACCURATE READINGS)

Falsely LOW BIS (reads deeper than actual)

CauseMechanism
High EMG activity (muscle relaxants given)Muscle relaxation removes high-frequency EMG that artificially raises BIS
HypothermiaSlows EEG → lower BIS
Ischaemia/hypoxiaCortical suppression
KetamineMay lower BIS paradoxically despite maintaining consciousness
Large haematoma over sensorSignal artifact

Falsely HIGH BIS (reads lighter than actual)

CauseMechanism
EMG interference (not using NMBDs)High-frequency muscle artifact raises BIS
Nitrous oxideDoes not significantly affect EEG - may keep BIS higher than expected
KetamineCan keep BIS high despite unconsciousness
Cardiac pacemakerElectrical artifact
ElectrocauteryInterference
DexmedetomidineCan give high BIS despite sedation (different EEG pattern)
Must Remember: Ketamine is a major confounding agent for BIS - it can cause dissociative anaesthesia while BIS remains > 70. BIS should NOT be relied upon to guide ketamine anaesthesia depth.

10. BIS AND AWARENESS - INCIDENCE DATA

PopulationAwareness Incidence
General surgical population0.1-0.2%
Cardiac surgery0.3-1.5%
Obstetric GA0.4%
Trauma GA1-2%
TIVA without monitoringUp to 1%
With BIS guidance (TIVA)<0.1%
Risk factors for awareness:
  • TIVA without EEG monitoring
  • Haemodynamic instability requiring low anaesthetic dose
  • Difficult airway (paralysed but under-anaesthetised)
  • Chronic drug/alcohol use (↑ MAC)
  • Prior awareness episode

11. NEUROMONITORING IN ICU (BIS FOR SEDATION)

Richmond Agitation-Sedation Scale (RASS) vs BIS Correlation

RASS ScoreDescriptionBIS Approx
+4Combative95-100
0Alert and calm80-95
-1 to -2Light sedation65-85
-3Moderate sedation50-70
-4Deep sedation40-55
-5Unarousable<40

Sedation Scales in ICU

ScaleParametersNotes
RASS-5 to +4Most widely used; guides BIS targets
SAS (Sedation-Agitation Scale)1-7Older scale
MAAS0-5Motor Activity Assessment Scale

12. BIS IN SPECIAL SITUATIONS

SituationBIS UseConsideration
TIVAPrimary depth monitorMost important indication
Cardiac surgeryBIS + raw EEGHypothermia affects interpretation
PaediatricsModified (not validated below age 1)Different EEG patterns
Neurological diseaseBaseline shiftedDementia patients have lower baseline
Brain deathBIS = 0, flat EEGConfirmatory adjunct
ECT (Electroconvulsive therapy)Monitors ictal activityBIS spikes during seizure, then falls

13. BIS vs ETAC MONITORING - COMPARISON

FeatureBIS MonitoringEnd-Tidal Agent Concentration (ETAC)
MeasuresBrain cortical activityAnaesthetic concentration
Applicable forALL anaesthetics (TIVA + volatile)Volatile agents only
Direct patient responseYes (brain EEG)No (surrogate: blood concentration)
Aware at BIS 40-600.1% chanceRare if ETAC >0.7 MAC
Evidence for awareness preventionEqual to ETACEqual to BIS (B-Unaware, BAG-RECALL)
CostHigher (sensor cost)Lower
TIVA casesMandatoryNot applicable

14. RECENT ADVANCES (2024-2026)

  • CODA Trial (2019): Avoiding burst suppression (BIS < 40) reduces postoperative delirium in elderly - reinforced in ESAIC 2023 guidelines
  • SedLine (Masimo PSi): 4-channel EEG (bilateral frontal) - better spatial coverage than single-channel BIS; detects hemispheric asymmetry
  • NeuroSENSE (WAM): Bilateral frontal EEG with WAVCNS index - parallel channels detect asymmetry
  • AI-enhanced EEG interpretation: Real-time spectrogram displays (hot maps) now integrated into anaesthesia workstations (Draeger, GE)
  • Closed-loop propofol delivery guided by BIS/EEG - multiple Phase III trials showing faster recovery and fewer awareness events (2023-2025)

15. CURRENT GUIDELINES

  • ASA Practice Advisory on Intraoperative Awareness (2006, updated 2023): BIS or ETAC monitoring recommended for high-risk awareness cases (TIVA, cardiac, obstetric GA, trauma)
  • ESAIC (2023): Quantitative EEG monitoring recommended during TIVA; avoid burst suppression (BIS <40) in elderly
  • SCCM PAD-ICU Guidelines (2018, update 2023): Objective sedation monitoring (RASS + BIS-guided) reduces ventilator days, ICU-LOS, and delirium

📌 EXAM PEARLS

  1. BIS 40-60 = target for GA - the single most asked numerical value about BIS
  2. BIS < 40 = burst suppression - associated with POCD and delirium in elderly - avoid
  3. BIS not reliable with ketamine - ketamine causes unconsciousness with high BIS values
  4. EMG interference raises BIS falsely - muscle relaxation removes EMG contamination and may cause BIS to DROP even though anaesthesia depth hasn't changed
  5. B-Aware (2004): BIS reduces awareness; B-Unaware/BAG-RECALL (2008/2011): ETAC equally effective - know all three trials
  6. TIVA without BIS = highest risk of awareness - BIS is essential in TIVA

🔴 HIGH YIELD FACTS

  • BIS is a dimensionless number 0-100 derived from frontal EEG processing
  • SQI > 80% needed for reliable BIS reading
  • BIS based on: BetaRatio + SynchFastSlow + BSR + QUAZI (4 sub-parameters)
  • Awareness incidence in general surgery = 0.1-0.2% (1-2 per 1000 anaesthetics)
  • Nitrous oxide and dexmedetomidine can give high BIS despite adequate sedation (different EEG mechanism)
  • Spectral Edge Frequency (SEF 95): Normal awake = ~20-25 Hz; GA = 8-12 Hz

References: Miller's Anesthesia 10e, Ch. 53; Barash Clinical Anesthesia 9e, Ch. 27; Morgan & Mikhail Clinical Anesthesiology 7e; B-Aware Trial (Myles, Lancet 2004); BAG-RECALL (Avidan, NEJM 2011); ESAIC 2023

Would you like to move on to the next question?
This is a shared conversation. Sign in to Orris to start your own chat.